Exhibit 10.2


 


IGI LABORATORIES, INC. 


 


and


 


ALVEDA PHARMACEUTICALS INC.


 


 






 


ASSET PURCHASE AGREEMENT


 


October 12th, 2015





 







 


 




     


     


    

 


ASSET PURCHASE AGREEMENT


 


THIS
ASSET PURCHASE AGREEMENT is entered into as of this 12th
day of October, 2015,


 


BETWEEN:


 


IGI LABORATORIES, INC.
a corporation existing under the laws of Delaware (“Purchaser”)


 


- and -


 


ALVEDA PHARMACEUTICALS INC.
a corporation existing under the laws of Canada (the “Vendor” or the “Company”)


 


RECITALS:


 


A.          The
Company carries on the business of developing, producing, marketing and distributing pharmaceutical products.


 


B.          The
Purchaser wishes to purchase and the Vendor wishes to sell, substantially all of the assets and undertakings of the Company upon
and subject to the terms and conditions contained in this Agreement.


 


NOW, THEREFORE,
for good and valuable consideration, the receipt and adequacy of which are hereby acknowledged by each party, the Parties agree
as follows:


 


Article
1 – DEFINITIONS AND interpretation


 


	Section 1.1	Definitions



 


Whenever used in this
Agreement, the following words and terms have the meanings set out below:


 


(1)          “Accounts
Receivable” means, with respect to the Company, all trade accounts and bills receivable, book debts and insurance claims
recorded as receivable in the Books and Records and other amounts due or deemed to be due to the Company (other than, in each case,
those owing by: (i) a Related Person; and/or (ii) in respect of an Excluded Asset; to the Company) including refunds and rebates
receivable, together with any unpaid interest accrued on such items and any security or collateral for such items, including recoverable
deposits, net of the allowance for doubtful accounts maintained in accordance with ASPE as set forth in the Financial Statements.


 


(2)          “Accrued
Liabilities” means ordinarily recurring operating expenses of the Company incurred as of the Closing Time but which are
not yet due and payable as of the Closing Time and claims against the Company that are increasing with the passage of time or receipt
of goods or services but are not yet due and payable as of the Closing Time, including accruals for vacation pay and customer rebates.


 




     


     


    

 


(3)          “Action”
means any litigation, action, application, suit, investigation, hearing, claim, complaint, deemed complaint, grievance, civil,
administrative, regulatory or criminal, arbitration proceeding or other similar proceeding, before or by any court, tribunal or
Governmental Authority, and includes any appeal or review thereof and any application for leave for appeal or review.


 


(4)          “Affiliate”
has the following meaning: an entity (the “first entity”) is the Affiliate of another entity (the “second
entity”) where the second entity controls the first entity, or the first entity controls the second entity or both entities
are controlled by the same Person or entity. For purposes of this definition, “control” is the power whether
by contract or ownership of equity interests to select a majority of the board of directors or other supervisory management authority
of an entity, whether directly or indirectly through a chain of entities that are “controlled” within the foregoing
meaning.


 


(5)          “Agreement”
means this Asset Purchase Agreement, including all schedules, and all amendments or restatements, as permitted, and references
to “Article” or “Section” mean the specified Article or Section of this Agreement.


 


(6)          “Ancillary
Documents” means any and all ancillary agreements, promissory notes, security agreements, releases, resignations, statutory
declarations and other documents and certificates to be delivered at or after Closing as part of the transactions contemplated
hereunder; including the Principal Shareholder Letter, the Transition Services Agreement and the Non-Competition Agreement.


 


(7)          “Basket”
has the meaning given to it in Section 7.6.


 


(8)          “Bethell
Contract” means the agreement dated October 1, 2011 between Michael Bethell and the Vendor.


 


(9)          “Books
and Records” means all information relating to the Business and in the possession or control of the Vendor, including,
without limitation, books of account, tax records, sales and purchase records, customer lists, formulae, Product Registrations,
Product dossiers and all regulatory submissions, filings and correspondence, documentation relating to formulary listings, requests
from healthcare professionals, Product circulars, safety update reports, adverse drug reports, complaint histories, technical documents
including specifications, business reports, standard operating procedures, plans and projections and all other documents, files,
correspondence and Corporate Records, whether in written or electronic form.


 


(10)         “Broker’s
Fee” means the amount payable to Bloom Burton & Co. Inc.,
as disclosed under Section 4.32.


 


(11)         “Business”
means the business of developing, producing, marketing, importing and distributing the Products, as conducted by the Company as
of the date of this Agreement.


 




     


     


    

 


(12)         “Business
Day” means any day, other than a Saturday or Sunday, on which commercial banks in Toronto, Ontario or New York, New York
are authorised or obligated by applicable Law to close.


 


(13)         “Business
IP” has the meaning given to it in Section 4.26(1).


 


(13a)       “Canadian Amount” means the Cash Portion as defined in an asset purchase agreement
dated October 12, 2015, between the Vendor and the Purchaser, which for greater certainty is not this Agreement.


 


(14)         “Cash”
means the aggregate of all cash or cash-equivalent assets that are readily convertible into cash (such as cheques and bills of
exchange or marketable securities) held by the Company, and any cash balances credited to the account of the Company with banks
or other financial institutions at the relevant time, including cash in transit from the Company to its banks, but excluding any
restricted cash or cash in transit from the clients or customers of the Company to the Company.


 


(15)         “Claim
Notice” has the meaning given to it in Section 7.4.


 


(16)         “Closing”
means the completion of the purchase and sale transactions contemplated in this Agreement.


 


(17)         “Closing
Agenda” means the list of documents agreed upon by counsel for the Purchaser and the Vendor to be delivered by the Purchaser
and the Vendor at the Closing.


 


(18)         “Closing
Date” means November 11, 2015 or such other date as the Purchaser and the Vendor may agree in writing as the date upon
which the Closing shall take place, provided that the Closing Date shall be no later than November 30, 2015.


 


(19)         “Closing
Date Balance Sheet” means the unaudited balance sheet of the Company as at the Closing Date, prepared in accordance with
ASPE and consistent with past practice.


 


(20)         “Closing
Time” means 10 o’clock a.m. (Toronto time), on the Closing Date or such other time on such date as the Parties
may agree in writing as the time at which the Closing shall take place.


 


(21)         “Consent”
means any consent, approval (including Regulatory Approvals), permit, waiver, ruling, exemption or acknowledgement from any Person
(other than the Vendor) which is provided for or required: (a) pursuant to the terms of any Contract; or (b) under any applicable
Law, in either case in connection with the sale of the Purchased Assets to the Purchaser on the terms contemplated in this Agreement,
to permit the Purchaser to use the Purchased Assets to carry on the Business after Closing, or which is otherwise necessary to
permit the Parties to perform their obligations under this Agreement.


 


(22)         “Contracts”
means any written or oral contracts, agreements, arrangements, commitments, obligation or undertaking (whether express or implied)
that is legally binding, or any outstanding offers made to or from a person that if accepted would be binding on such person.


 


(23)         “Corporate
Records” means the corporate records of the Company and any predecessor companies thereof including (a) all constating
documents and by-laws; (b) all minutes of meetings and resolutions of shareholders and directors (and any committees); and (c)
the share certificate books, securities register, register of transfers and register of directors and officers.


 




     


     


    

 


(24)        “Company”
has the meaning given to it in the recitals to this Agreement.


 


(25)        “Confidential
Information” means, in relation to a Party (the “Discloser”):


 


		(a)	all information, in whatever form communicated or maintained, that the Discloser discloses to,
or that is gathered by inspection by a Party (the “Recipient”) or any of the Recipient’s Representatives
in the course of the Recipient’s review of the transactions contemplated by this Agreement, whether provided before or after
the date of this Agreement, that contains or otherwise reflects information concerning the Discloser or its businesses, affairs,
financial condition, assets, liabilities, operations, prospects or activities;



 


		(b)	all plans, proposals, reports, analyses, notes, studies, forecasts, compilations or other information,
in any form, that are based on, contain or reflect any Confidential Information regardless of the identity of the Person preparing
the same; and



 


		(c)	any matter relating to this Agreement or its terms;



 


but does not include any information
that:


 


		(d)	is at the time of disclosure to the Recipient or thereafter becomes generally available to the
public, other than as a result of a disclosure by the Recipient or any of the Recipient’s Representatives in breach of this
Agreement;



 


		(e)	is or was received by the Recipient on a non-confidential basis from a source other than the Discloser
or its Representatives if such source is not prohibited from disclosing the information to the Recipient by a contractual, fiduciary
or other legal confidentiality obligation to, the Discloser; or



 


		(f)	was known by the Recipient prior to disclosure in connection with the transactions contemplated
by this Agreement and was not subject to any contractual, fiduciary or other legal confidentiality obligation on the part of the
Recipient.



 


(26)        “Delayed
Transfer Asset” has the meaning given to it in Section 8.2(1).


 


(27)        “Delayed
Transfer Liabilities” has the meaning given to it in Section 8.2(2).


 


(28)        “Direct
Claim” has the meaning given to it in Section 7.4.


 


(29)        “Discloser”
has the meaning set out in the definition of Confidential Information.


 


(30)        “Encumbrance”
means any pledges, liens, charges, security interests, leases, title retention agreements, mortgages, restrictions, developments
or similar agreements, easements, rights-of-way, title defects, options or adverse claims or encumbrances of any kind or character
whatsoever.


 




     


     


    

 


(31)          “Environmental
Laws” means any Law governing matters arising out of, relating to, or resulting from pollution, contamination, protection
of the environment, human health or safety, health or safety of employees, sanitation, and any matters relating to emissions, discharges,
disseminations, releases or threatened releases, of Hazardous Materials into the air (indoor and outdoor), surface water, groundwater,
soil, land surface or subsurface, buildings, facilities, real or personal property or fixtures or otherwise arising out of, relating
to, or resulting from the manufacture, processing, distribution, use, treatment, storage, disposal, transport, handling, release
or threatened release of Hazardous Materials.


 


(32)          “Environmental
Permits” has the meaning ascribed thereto in Section 4.33.


 





(33)          “Excluded Assets” means (i) all Cash, (ii) all Inventory and Accounts Receivable, (iii)
all Contracts not listed and described in Schedule 1.1(69), (iv) all amounts
due by Related Persons of the Vendor, (vi) capital assets, (vii) all Intellectual Property not listed in Schedule 1.1(69), (viii)
Operational Permits, (ix) all items of furniture and equipment, including computer hardware, located at the Leasehold Premises
and (x) items personal to Albert Beraldo, as set out on Schedule 1.1(33).


 





(34)          “Excluded
Liabilities” means all Liabilities other than in respect of or associated with: (i) Transfer Taxes properly payable upon
and in connection with the sale, assignment and transfer of the Purchased Assets from the Vendor to the Purchaser; or (ii) the
Purchased Assets.


 


(35)          “Extraordinary
Claim” has the meaning given to it in Section 3.4.


 


(36)          “Financial
Statements” means the financial statements of the Company as at and for the fiscal year ended September
30, 2014, consisting of a balance sheet, statement of income and retained earnings and any notes thereto.


 


(37)          
“Goodwill” means the goodwill of the Business, including, without limitation, the exclusive right of the Company
to (i) represent itself as carrying on the Business, and (ii) use any words indicating that the Business is so carried on, including
all of the Company’s right, title and interest in and to the name “Alveda Pharmaceuticals Inc.”, or any variation
thereof, together with the rights, if any, to telephone and facsimile numbers and internet domain names used in connection with
the Business.


 


(38)          “Governmental
Authorisations” means authorisations, approvals, including environmental approvals, franchises, orders, certificates,
consents, directives, notices, licences, permits, variances, agreements, instructions, registrations or other rights issued to
or required by the Company by or from any Governmental Authority.


 


(39)          
“Governmental Authority” means any (a) multinational, federal, provincial, regional, municipal, local or
other government, governmental or public department, central bank, court, tribunal, arbitral body, statutory body, commission,
board, bureau or agency, domestic or foreign, including without limitation, Health Canada, (b) any subdivision, agent, commission,
board, or authority of any of the foregoing, or (c) any quasi-governmental or private body exercising any regulatory, expropriation
or Taxing Authority under or for the account of any of the foregoing.


 




     


     


    

 


(40)          “Hazardous
Materials” means any pollutants, contaminants, toxic or hazardous or extremely hazardous substances, materials, wastes,
constituents, compounds, chemicals, natural or man-made elements or forces (including petroleum or any by-products or fractions
thereof, any form of natural gas, lead, asbestos and asbestos-containing materials, building construction materials and debris,
polychlorinated biphenyls (“PCBs”) and PCB-containing equipment, and radon and other radioactive elements that
are regulated by any Environmental Laws.


 


(41)          
“Indebtedness” means any Liability (other than Excluded Liabilities) of the Company (a) for term debt, lines
of credit or any other borrowed money, (b) under any reimbursement obligation relating to a letter of credit, bankers’ acceptance
or note purchase facility, (c) evidenced by a bond, note, debenture or similar instrument (including a purchase money obligation),
(d) for the payment of money relating to leases that are required to be classified as a capitalised lease obligation in accordance
with ASPE, (e) under any derivative, hedging or similar agreements (including interest rate, currency or commodity swap agreements,
cap agreements, collar agreements or any other agreements or arrangements designed to protect the Company against fluctuations
in interest rate, currency exchange rates or commodity prices), (f) for any interest related to the foregoing, and (g) as obligor,
guarantor, surety or otherwise of any of the foregoing.


 


(42)          “Indemnified
Party” means a Person whom the Vendor or the Purchaser, as the case may be, is required to indemnify under Article 7.


 


(43)          “Indemnifying
Party” means, in relation to an Indemnified Party, the Party that is required to indemnify such Indemnified Party under
Article 7.


 


(44)          “Indemnity
Period” has the meaning given to it in Section 7.5(1).


 


(45)          “Intellectual
Property” means all patents and patent rights, trademarks and trademark rights, trade names and trade name rights, inventions,
processes, formulae, copyrights and copyright rights, trade dress, business names, logos, slogans, domain names, trade secrets,
processes, inventions, designs, specifications, data, technology, methodologies, computer programs, confidential and proprietary
information, whether or not subject to statutory registration, and all related technical information, manufacturing, engineering
and technical drawings, know-how and all pending applications for and registrations of patents, trademarks and copyrights, including
all unregistered Intellectual Property rights pertaining to the business of the Company, in connection with any of the foregoing,
and all documents, disks and other media on which any of the foregoing is stored.


 


(46)          “Interim
Period” means the period from the date of execution of this Agreement to the Closing Time.


 


(47)          “Inventory”
means all saleable finished Product inventory of the Business on hand at the premises of the Company at the close of business on
the day preceding the Closing Date.


 




     


     


    

 


(48)          “Laws”
means all statutes, regulations, statutory rules, ordinances, binding guidance documents, common law, orders, decrees, and terms
and conditions of any grant of approval, permission, authority or license of any Governmental Authority and the term “applicable”
with respect to such Laws and in the context that refers to one or more persons, means that such Laws apply to such person or persons
or its or their business, undertaking, assets, property or securities (whether equity or debt) and emanate from any Governmental
Authority having jurisdiction over the person or persons or its or their business, undertaking, assets, property or securities
(whether equity or debt).


 


(49)          “Leases”
means all leases, subleases, licenses, or rights to occupy or use Real Property, including, in each case, all amendments, modifications
and supplements thereto and waivers and consents thereunder.


 


(50)          “Leasehold
Premises” has the meaning ascribed thereto in Section 4.14.


 


(51)          “Liability”
means any liability, debt, obligation, penalty, fine, claim or other loss, cost or expense of any kind or nature whatsoever, whether
asserted or unasserted, absolute or contingent, known or unknown, accrued or unaccrued, liquidated or unliquidated, and whether
due or to become due and regardless of when asserted.


 


(52)          “Licenses”
has the meaning given to it in Section 4.15(1).


 


(53)          “Losses”
in respect of any matter, means all third party claims, demands, proceedings, losses, damages, liabilities, deficiencies, fines,
penalties, costs and expenses, contingent or otherwise, whether liquidated or unliquidated, matured or unmatured, disputed or undisputed,
contractual, legal or equitable (including, without limitation, loss of value and all legal and other professional fees and disbursements,
interest, penalties and amounts paid in settlement) arising directly or indirectly as a consequence of such matter, net of proceeds
of insurance.


 


(54)          “Material
Contracts” has the meaning given to it in Section 4.20(1).


 


(55)          “Material
Proceeding” has the meaning given to it in Section 7.11(b).


 


(56)          “Non-Competition
Agreement” means the non-competition and non-solicitation agreement to be entered into between Purchaser and the
Principal Shareholder on the Closing Date; substantially in the form attached as Exhibit A.


 


(57)          “Non-Disclosure
Agreement” means the non-disclosure agreement entered into between Purchaser and its Affiliates, and the Company,
dated June 5, 2015.


 


(58)          “Operational
Permits” means Establishment Licenses (ELs) issued under the regulations under the Food and Drug Act (including,
if applicable, the Natural Health Products Regulations) and the Food and Drug Regulations, and all licenses and permits
issued under regulations to the Controlled Drugs and Substances Act, and all applications and submissions for such Operational
Permits.


 




     


     


    

 


(59)        “Ordinary
Course” means, with respect to an action taken by a Person, that such action is consistent with the past practices of
such Person and is taken in the ordinary course of the normal day-to-day operations of such Person.


 


(60)        “Parties”
means the Vendor and the Purchaser collectively, and “Party” means any one of them.


 


(61)        
“Pension Plans” means all Employee Plans providing pensions, superannuation benefits, retirement savings, top
up or supplemental pensions, “registered retirement savings plans” (as defined in the Tax Act), “registered pension
plans” (as defined in the Tax Act) or “retirement compensation arrangements” (as defined in the Tax Act).


 


(62)        “Permitted
Encumbrance” means: (i) those items listed in Schedule 1.1(62); (ii) liens for Taxes not yet due and payable; (iii) mechanics,
carriers’, workmen’s, repairmen’s or other like liens arising or incurred in the ordinary course of business
consistent with past practice or amounts that are not delinquent and which are not, individually or in the aggregate, material
to the Business; (iv) easements, rights of way, zoning ordinances and other similar encumbrances affecting Real Property which
are not, individually or in the aggregate, material to the Business; and/or (v) liens arising under original purchase price conditional
sales contracts and equipment leases with third parties entered into in the ordinary course of business consistent with past practice
which are not, individually or in the aggregate, material to the Business.


 


(63)        “Person”
means any individual, corporation, legal person, partnership, firm, joint venture, syndicate, association, trust, trustee, limited
liability company, unincorporated organisation, trust company, Governmental Authority or any other form of entity or organisation.


 


(64)        “Principal
Shareholder” means Mr. Albert Beraldo, shareholder of the Vendor, resident at 15 Balmoral Ave., Toronto, Ontario, M4V
1J5.


 


(65)        “Principal
Shareholder Letter” means the letter, substantially in the form attached as Exhibit B, dated on or around the Closing
Date, addressed to the Purchaser from the Principal Shareholder.


 


(66)        “Product
Registrations” means all Governmental Authorisations relating to manufacture, fabrication, packaging, labelling, sale,
possession, importation and distribution of the Products, including, without limitation, the Drug Identification Numbers (DINs),
and Notices of Compliance (NOCs) but excluding the Operational Permits.


 


(67)        “Products”
means all of the products developed or manufactured, marketed, imported, sold, distributed or licensed by the Company; and “Product”
means any one of the foregoing.


 


(68)        “Purchase
Price” has the meaning given to it in Section 2.4(1).


 


(69)        “Purchased
Assets” means all of the undertaking, property and assets of every kind and description wherever situated, relating to
the Business, other than the Excluded Assets, including:


 


		(a)	all Contracts relating to the Business listed in Schedule 1.1(69)



 




     


     


    

 


		(b)	the Intellectual Property of the Business listed in Schedule 1.1(69);



 


		(c)	Goodwill;



 


		(d)	all Product Registrations and, to the extent, assignable and transferable, all other listings of
the Company for the Products in provincial formularies; and



 


		(e)	the Books and Records relating directly to the foregoing items (a) through (d).



 


(70)        “Purchaser”
has the meaning given to it in the recitals to this Agreement.


 


(71)        “Purchaser
Indemnified Parties” has the meaning given to it in Section 7.2.


 


(72)        “Real
Property” has the meaning given to it in Section 4.14.


 


(73)        “Recipient”
has the meaning set out in the definition of Confidential Information.


 


(74)        “Regulatory
Approval” means any approval, consent, ruling, authorization, notice, permit or acknowledgment that may be required from
any person pursuant to applicable Law or under the terms of any licence or the conditions of any order in connection with the sale
of the Purchased Assets to the Purchaser on the terms contemplated in this Agreement, to permit the Company to carry on the Business
after the Closing Date, including without limitation, all Product Registrations, or which is otherwise necessary to permit the
Parties to perform their obligations under this Agreement.


 


(75)        “Related
Person” means a Person that is related to, or affiliated or associated with, or otherwise not acting at arm’s length
with, the Company, and, for these purposes, shall include 6813852 Canada Inc. (d.b.a. Idoman Canada) and 6770215 Canada Inc. and
their respective Affiliates and associates, and any of their directors and officers.


 


(76)        “Representative”
when used with respect to a Person means each director, officer, employee, consultant, financial adviser, legal counsel, accountant
and other agent, adviser or representative of that Person.


 


(77)        “Tax”
and “Taxes” mean, with respect to any Person, all federal, local, foreign, provincial, territorial or municipal
or other taxes, customs, tariffs, imposts, levies, duties, government fees or other like assessments or charges of any kind, including
all income, gains, franchise, sales, use, ad valorem, goods and services, harmonized sales, transfer, land transfer, license, recording,
withholding, capital, employment (including federal, provincial and state income tax withholding, backup withholding, Canada pension
plan, Québec pension plan, employment insurance, employer health tax, workers compensation premiums or other payroll taxes,
contributions, deductions, withholdings, premiums and remittances, including in respect of employment outside of Canada and the
United States), environmental, excise, severance, stamp, occupation, premium, prohibited transaction, property, value-added, net
worth, or any other taxes and any instalments, interest, penalties, fines and additions imposed or required with respect to such
amounts, and whether contested or not.


 


(78)        “Tax
Act” means, the Income Tax Act (Canada), as amended.


 




     


     


    

 


(79)          “Tax
Legislation” means, collectively, the Tax Act, the Excise Tax Act (Canada), as amended, and all Laws of
any jurisdiction or sub-jurisdiction, domestic or foreign in relation to Taxes.


 


(80)          “Tax
Return” means any return (including an information return), declaration, report, statement, claim for a refund, rebate
or credit, amended return, declaration of estimated Taxes, election, designation or other document (including any attached schedule
and any attached related or supporting information) relating to Taxes filed or required to be filed under any applicable Tax Legislation
or in fact filed with any Taxing Authority.


 


(81)          “Taxing
Authority” means any Governmental Authority, domestic or foreign, having jurisdiction over the assessment, determination,
collection or other imposition of any Tax.


 


(82)          “Third
Party” any Person that is not the Vendor, the Purchaser, or their Affiliates or Related Persons.


 


(83)          “Third
Party Claim” means a claim by a Third Party against the Indemnified Party which, for greater certainty, includes an assessment
or reassessment in respect of Taxes.


 


(84)          “Transfer
Taxes” has the meaning given to it in Section 2.5(1).


 


(85)          “Transition
Services Agreement” means the Transition Services Agreement to be entered into between the Purchaser, the Vendor, and
the Principal Shareholder in respect of the period starting on the Closing Date and ending six (6) months thereafter.


 


(86)          “Vendor”
has the meaning given to it in the recitals to this Agreement.


 


(87)          “Vendor
Fundamental Representations” has the meaning given to it in Section 7.5(1)(a).


 


(88)          “Vendor
Indemnified Parties” has the meaning given to it in Section 7.3.


 


	Section  1.2	Certain Rules of Interpretation



 


In this Agreement:


 


(1)          Consent
– Whenever a provision of this Agreement requires an approval or consent and such approval or consent is not delivered within
the applicable time limit, then, unless otherwise specified, the Party whose consent or approval is required shall be conclusively
deemed to have withheld its approval or consent.


 


(2)          Currency
– Unless otherwise specified, all references to money amounts are to lawful currency of Canada.


 


(3)          Governing
Law – This Agreement is a contract made under and shall be governed by and construed in accordance with the Laws of the
Province of Ontario and the federal Laws of Canada applicable in the Province of Ontario. The United Nations Convention on Contracts
for the International Sale of Goods (CISG) and the International Sale of Goods Act (Ontario) are expressly excluded.


 




     


     


    

 


(4)          Court
of Competent Jurisdiction – References to a court of competent jurisdiction refers solely and exclusively to any court
situate in the Province of Ontario, Canada, having jurisdiction to hear and decide any dispute pertaining to this Agreement.


 


(5)          Headings
– Headings of Articles and Sections are inserted for convenience of reference only and do not affect the construction or
interpretation of this Agreement.


 


(6)          Including
– Where the word “including” or “includes” is used in this Agreement, it means “including
(or includes) without limitation”.


 


(7)          No
Strict Construction – The language used in this Agreement is the language chosen by the Parties to express their mutual
intent, and no rule of strict construction shall be applied against any Party.


 


(8)          Number
and Gender – Unless the context otherwise requires, words importing the singular include the plural and vice versa and
words importing gender include all genders.


 


(9)          Severability
– If, in any jurisdiction, any provision of this Agreement or its application to any Party or circumstance is restricted,
prohibited or unenforceable, such provision shall, as to such jurisdiction, be ineffective only to the extent of such restriction,
prohibition or unenforceability without invalidating the remaining provisions of this Agreement and without affecting the validity
or enforceability of such provision in any other jurisdiction or without affecting its application to other Parties or circumstances.


 


(10)          Statutory
references – A reference to a statute includes all regulations and rules made pursuant to such statute and, unless otherwise
specified, the provisions of any statute, regulation or rule which amends, supplements or supersedes any such statute, regulation
or rule.


 


(11)          Time
– Time is of the essence in the performance of the Parties’ respective obligations.


 


(12)          Time
Periods – Unless otherwise specified, time periods within or following which any payment is to be made or act is to be
done shall be calculated by excluding the day on which the period commences and including the day on which the period ends and
by extending the period to the next Business Day following if the last day of the period is not a Business Day.


 


	Section  1.3	Knowledge of the Vendor



 


Whenever used in this
Agreement, the expression “to the knowledge of the Vendor” and similar expressions mean in connection with this
Agreement, the actual and constructive knowledge of Albert Beraldo after making relevant inquiries with the level of diligence
expected from a reasonably prudent merchant.


 




     


     


    

 


	Section 1.4	ASPE



 


Wherever in this Agreement
reference is made to a calculation to be made or financial statements to be prepared in accordance with ASPE, the reference is
to Canadian accounting standards for private enterprises under Part II of the CICA Handbook of the Canadian Institute of Chartered
Accountants, as amended at any time, applicable as at the date on which the calculation is made or required to be made in accordance
with ASPE.


 


	Section 1.5	Entire Agreement



 


This Agreement, together
with the Non-Disclosure Agreement, the Transition Services Agreement, the Non-Competition Agreement and the other agreements and
documents required to be delivered pursuant to this Agreement, constitute the entire agreement between the Parties and set out
all the covenants, promises, warranties, representations, conditions and agreements between the Parties in connection with the
subject matter of this Agreement and supersede all prior agreements, understandings, negotiations and discussions, whether oral
or written, pre-contractual or otherwise, including the binding offer letter of the Purchaser dated September 4, 2015. There are
no covenants, promises, warranties, representations, conditions, understandings or other agreements, whether oral or written, pre-contractual
or otherwise, express, implied or collateral between the Parties in connection with the subject matter of this Agreement except
as specifically set forth in this Agreement and any document required to be delivered pursuant to this Agreement.


 


	Section 1.6	Schedules; Exhibits



 


The following schedules
are annexed to this Agreement and are incorporated by reference and deemed to be a part hereof:


 


	 	Schedule	 	Title
	 	 	 	 
	 	1.1(33)	 	Excluded Assets
	 	1.1(62)	 	Permitted Encumbrances
	 	1.1(69)	 	Purchased Assets
	 	2.6	 	Purchase Price Allocation
	 	3.1(e)(iii)	 	Closing Consents
	 	4.10	 	Consents
	 	4.13	 	Compliance with Law
	 	4.14	 	Real Property
	 	4.15	 	Licenses
	 	4.16	 	Litigation
	 	4.17	 	Regulatory Matters
	 	4.19	 	Undisclosed Liabilities
	 	4.20	 	Material Contracts
	 	4.21	 	Commission Arrangements
	 	4.22	 	Suppliers and Customers
	 	4.23	 	Non-Arm’s Length Transactions
	 	4.24	 	Insurance
	 	4.25	 	Intellectual Property
	 	4.27	 	Tax Matters
	 	4.28	 	No Broker (Vendor)




	 	4.30	 	Product and Product Registrations
	 	4.31	 	Warranties and Product Liability
	 	4.34	 	Absence of Changes
	 	5.1(4)	 	No Broker (Purchaser)


 




     


     


    

 


	 	Exhibit	 	Title
	 	 	 	 
	 	A	 	Non-Competition Agreement
	 	B	 	Principal Shareholder Letter
	 	C	 	Sublet Agreement


 


Article
2 – PURCHASE OF the PUrchased Assets


 


	Section 2.1	Purchase and Sale



 


(1)          On
the Closing Date, the Vendor shall sell and the Purchaser shall purchase all of the Purchased Assets upon and subject to the terms
and conditions of this Agreement and as set out below.


 


(2)          The
Closing shall take place at the Closing Time by electronic exchange of documents, or at such other time on the Closing Date or
such other place as may be agreed by the Vendor and the Purchaser.


 


	Section 2.2	Closing Deliverables by Purchaser



 


(1)          In
addition to any other documents to be delivered under other provisions of this Agreement or as set forth in the Closing Agenda,
at the Closing or at such other date and time contemplated herein, in any Ancillary Documents or the Closing Agenda, the Purchaser
shall deliver to the Vendor:


 


		(a)	the payments due on Closing in accordance with Section 2.4;



 


		(b)	duly executed director and shareholder resolutions of the Purchaser approving the transactions
contemplated by this Agreement and all Ancillary Documents to which the Purchaser is party;



 


		(c)	the Non-Competition Agreement, duly executed by the Purchaser;



 


		(d)	the Transition Services Agreement duly executed by the Purchaser;



 


		(e)	a general conveyance and assumption of liabilities agreement, duly executed by the Purchaser;



 


		(f)	a certificate or declaration dated as of the Closing Date and executed by a duly authorised officer
in a form reasonably acceptable to the Vendor, confirming the matters applicable to the Purchaser in Article 4; and



 




     


     


    

 


		(g)	such other documents and instruments as may reasonably be requested by the Vendor, each in form and
substance satisfactory to the Vendor and their legal counsel and duly executed on behalf of the Purchaser.



 


	Section 2.3	Closing Deliverables by the Vendor



 


		(1)	In addition to any other documents to be delivered under other provisions of this Agreement or
as set forth in the Closing Agenda, at the Closing or at such other date and time contemplated herein, in any Ancillary Documents
or the Closing Agenda, the Vendor shall deliver (and in the case of items (c), (d), (e) and (f) shall ensure that the Principal
Shareholder delivers) to the Purchaser:



 


		(a)	duly executed director and shareholder resolutions of the Vendor approving the transactions contemplated
by this Agreement and all Ancillary Documents to which the Vendor is party;



 


		(b)	if required by Health Canada or similar organisation anywhere in the world, a transfer of authorisations
and rights, in form satisfactory to the Purchaser acting reasonably, with respect to the Products sold, imported, distributed,
or marketed by the Company;



 


		(c)	the Non-Competition Agreement, duly executed by the Principal Shareholder;



 


		(d)	the Principal Shareholder Letter, duly executed by the Principal Shareholder;



 


		(e)	the Transition Services Agreement duly executed by the Vendor and the Principal Shareholder;



 


		(f)	a general conveyance and assumption of liabilities agreement, duly executed by the Vendor and any
specific conveyance and assumption of liabilities agreements that may be required;



 


		(g)	physical possession of any tangible Purchased Assets;



 


		(h)	the Consents, unless the requirement to receive a Consent has been waived by the Purchaser in its
sole discretion, or the Vendor has delivered a written undertaking to obtain a Consent within a reasonable delay following the
Closing;



 


		(i)	duly executed pay-off letters, releases, discharges or other similar instruments and estoppel letters,
as applicable, in a form satisfactory to the Purchaser, acting reasonably, providing for the release of any Encumbrances other
than Permitted Encumbrances, affecting the Purchased Assets;



 


		(j)	a certificate or declaration dated as of the Closing Date and executed by a duly authorised officer
in a form reasonably acceptable to the Purchaser, confirming the matters applicable to the Vendor in Article 5, with updated Schedules
to this Agreement to be delivered at Closing;



 




     


     


    

 


		(k)	deeds, conveyances, assurances, transfers and assignments and any other instruments necessary or
reasonably required, and in forms acceptable to the Vendor, acting reasonably, to transfer the Purchased Assets to the Purchaser
with a good title, free and clear of all Encumbrances other than any Permitted Encumbrances, including a release of security registrations
by any shareholder of the Vendor against the Purchased Assets; and



 


		(l)	such other documents and instruments as may reasonably be requested by the Purchaser, each in form
and substance satisfactory to the Purchaser and their legal counsel and duly executed on behalf of the Vendor.



 


	Section 2.4	Purchase Price



 





(1)          The aggregate purchase price payable by the Purchaser to the Vendor for the Purchased Assets is an amount
equal to (i) $47,000,000 minus the Canadian Amount (the “Purchase Price”); which shall be allocated to the Purchased
Assets as contemplated in Section 2.6 and set out in Schedule 2.6, shall
be paid by the Purchaser to the Vendor at Closing.


 





	Section 2.5	Payment of Sales Taxes and Tax Elections



 


(1)          Transfer
Taxes. The Purchaser shall be liable for and shall pay all sales, goods and services, harmonized sales, value added, use, transfer,
and similar Taxes (“Transfer Taxes”) properly payable upon and in connection with the sale, assignment and transfer
of the Purchased Assets from the Vendor to the Purchaser, other than any Taxes which are imposed on the Vendor under applicable
Laws, including Taxes payable on the Vendor’s net income, profits or gains. The Purchaser shall pay such Transfer Taxes directly
to the Vendor against proper invoice or bill of sale from the Vendor separately indicating the applicable Transfer Taxes and the
Vendor’s relevant Transfer Tax registration number(s). The Vendor shall remit such Transfer Taxes directly to the relevant
taxation authority.


 


(2)          Subsection
20(24) Tax Election. The Purchaser and the Vendor shall, if requested by the Purchaser, jointly execute and file an election
under subsection 20(24) of the Tax Act in the manner required by subsection 20(25) of the Tax Act and under the equivalent or corresponding
provisions of any other applicable provincial or territorial statute, in the prescribed forms and within the time period permitted
under the Tax Act and under any other applicable provincial or territorial statute, as to such amount paid by the Vendor to the
Purchaser for assuming future obligations. In this regard, the Purchaser and the Vendor acknowledge that a portion of the Purchased
Assets transferred by the Vendor pursuant to this Agreement and having a value equal to the amount elected under subsection 20(24)
of the Tax Act and the equivalent provisions of any applicable provincial or territorial statute, is being transferred by the Vendor
as a payment for the assumption of such future obligations by the Purchaser.


 


	Section 2.6	Allocation of Purchase Price



 


The
parties agree that the Purchase Price shall be allocated among the Purchased Assets in the manner set forth in Schedule 2.6. The
Purchaser and the Vendor shall report an allocation of the Purchase Price among the Purchased Assets in a manner entirely consistent
with Schedule 2.6 and shall not take any position inconsistent therewith in the filing of any Tax Returns or in the course of any
audit by any Governmental Authority, Tax review or Tax proceeding relating to any Tax Returns. 


 




     


     


    

 


Article
3 – cONDITIONS OF CLOSING


 


	Section 3.1	Conditions to Obligations of the Purchaser



 


(1)          The
obligation of the Purchaser to consummate the transactions contemplated herein is subject to the satisfaction, at
or before the Closing, of the following conditions, any or all of which may be waived, in whole or in part, in writing, to the
extent permitted by applicable Law, by the Purchaser in its sole discretion:


 


		(a)	No Injunction. There shall
be (a) no action or proceeding, before any Governmental Authority, pending which, if adversely decided, would reasonably be expected
to result in a judgement, decree or order that would prevent the carrying out of this Agreement or any of the transactions contemplated
hereby, declare unlawful the transactions contemplated hereby or cause such transactions to be rescinded and (b) no Law shall have
been enacted, and no order, decree or other pronouncement of any Governmental Authority shall have been made, that prevents the
carrying out of this Agreement or any of the transactions contemplated hereby, declares unlawful the transactions contemplated
hereby or causes such actions to be rescinded.



 


		(b)	Authorisations. Each
Governmental Authorisation necessary to be obtained in connection with the execution and delivery of this Agreement or any
other agreements contemplated hereby or the transactions contemplated hereby or thereby shall have been made, given or obtained.



 


		(c)	Product Registrations. The Vendor shall have transferred or assigned
to the Purchaser, or the Purchaser will have otherwise acquired, all Product Registrations necessary to carry on the Business in
the Ordinary Course.



 


		(d)	Formulary Listings. The Vendor shall have transferred or assigned
to the Purchaser all listings of the Company for the Products in provincial formularies.



 


		(e)	Agreements and Documents.
The Purchaser shall have received the following items from the Vendor, each of which, to the extent applicable, shall be in full
force and effect:



 


		(i)	the Purchaser shall have been assigned the Company’s Contracts to the extent such Contracts are
included in the Purchased Assets; subject to Section 3.1(e)(iii), it being
understood that this condition solely relates to the failure to assign a Contract for lack of Consent only in respect of those
Contracts listed in Schedule 3.1(e)(iii);







 


		(ii)	the Company shall have received, and shall be continuing to receive, all supply of Inventory in
the Ordinary Course, in a manner consistent with the understandings established in new and existing supply agreements;



 




     


     


    

 


		(iii)	all Consents to assign the Contracts listed in Schedule 3.1(e)(iii), unless the requirement to receive
such Consent has been waived by the Purchaser in its sole discretion, or the Vendor has delivered a written undertaking to obtain
such Consent within a reasonable delay following the Closing;







 


		(iv)	the Purchaser shall be satisfied, acting reasonably, that the Vendor has no material issues with
respect to Health Canada regulatory matters that cannot be resolved with good faith efforts and cooperation of the Parties, and
that no material issues with respect to Health Canada regulatory matters shall arise as a result of the transactions contemplated
hereby;



 


		(v)	a recent certificate of status or similar certificate with respect to the Company, issued by the
appropriate Governmental Authority of its jurisdiction of incorporation;



 


		(vi)	certified copies of (i) the constating documents and by-laws of the Company; and (ii) the resolutions
of the shareholders and the sole director of the Company consenting to the transfer of the Purchased Assets pursuant to the terms
of the Agreement;



 


		(vii)	a certificate of an officer of the Company confirming that there are no known or reported Liabilities
of the Company current or outstanding as of the Closing Time, which Liabilities could be attached to the Purchased Assets or the
Purchaser, save for Excluded Liabilities and liabilities owing to Governmental Authorities (such as HST or source deductions),
trade payables, salaries or other accruals incurred in the Ordinary Course and not yet due, and amounts in respect of the capital
lease obligations;



 


		(viii)	a certificate from the Vendor confirming the covenants in this Agreement made by the Vendor and
the representations and warranties in Article 4 of this Agreement are true and correct in all material respects as at the Closing
Date and the Closing Time (except those representations and warranties that address matters only as of a specified date, the accuracy
of which shall be determined as of that specified date in all material respects; and those representations and warranties in respect
of Vendor Fundamental Representations, each of which must be true and correct in all respects); it being understood that the Vendor
shall be entitled to deliver updated Schedules to this Agreement at Closing;



 


		(ix)	evidence that all Encumbrances against the Purchased Assets have been released and discharged;



 


		(x)	a general conveyance and assumption of liabilities agreement, duly executed by the Vendor;



 


		(xi)	physical possession of any tangible Purchased Assets; and



 




     


     


    

 


		(xii)	the Company shall have delivered the Financial Statements and the Books and Records to the Purchaser,
to the extent such Financial Statements and Books and Records relate to the Purchased Assets.



 


(2)          Condition
Not Fulfilled. If any condition in Section 3.1(1) (other than in Section 3.1(d)(i), (ii) and (xii), for which the Purchaser
shall have no termination right) has not been fulfilled at or before the Closing Time or if any such condition is, or becomes,
impossible to satisfy prior to the Closing Time, other than as a result of the failure of the Purchaser to comply with its obligations
under this Agreement, then the Purchaser in its sole discretion may, without limiting any rights or remedies available to the Purchaser
at law or in equity, either:


 


		(a)	terminate this Agreement by notice to the Vendor, as provided in Section 3.5; or



 


		(b)	waive compliance with any such condition without prejudice to its right of termination in the event
of non-fulfilment of any other condition.



 


	Section 3.2	Conditions to Obligations of the Vendor



 


(1)          The
obligation of the Vendor to consummate the transactions contemplated herein is subject to the satisfaction, on or before the Closing,
of the following conditions, any or all of which may be waived, in whole or in part, to the extent permitted by applicable Law,
by the Vendor in its sole discretion:


 


		(a)	No Injunction. There shall
be (a) no action or proceeding, before any Governmental Authority, pending which, if adversely decided, would reasonably be expected
to result in a judgement, decree or order that would prevent the carrying out of this Agreement or any of the transactions contemplated
hereby, declare unlawful the transactions contemplated hereby or cause such transactions to be rescinded and (b) no Law shall have
been enacted, and no order, notice, decree or other pronouncement of any Governmental Authority shall have been made, that prevents
the carrying out of this Agreement or any of the transactions contemplated hereby, declares unlawful the transactions contemplated
hereby or causes such actions to be rescinded.



 


		(b)	Authorisations.
Each Governmental Authorisation necessary to be obtained in connection with the execution and delivery of this Agreement
or any other agreements contemplated hereby or the transactions contemplated hereby or thereby shall have been made, given or obtained.



 


		(c)	Agreement and Documents.
The Company shall have received the following items from the Vendor, each of which, to the extent applicable, shall be in full
force and effect:



 


		(i)	a recent certificate of status or similar certificate with respect to the Purchaser, issued by
the appropriate Governmental Authority of its jurisdiction of incorporation;



 




     


     


    

 


		(ii)	certified copies of (i) the constating documents and by-laws of the Purchaser; and (ii) the resolutions
of the shareholders and the sole director of the Purchaser authorising the purchase of the Purchased Assets pursuant to the terms
of the Agreement; and



 


		(iii)	a certificate from the Purchaser confirming the covenants in this Agreement made by the Purchaser
and the representations and warranties in Article 5 of this Agreement are true and correct in all material respects as at the Closing
Date and the Closing Time (except those representations and warranties that address matters only as of a specified date, the accuracy
of which shall be determined as of that specified date in all material respects.)



 


(2)          Condition
Not Fulfilled. If any condition in Section 3.2(1) has not been fulfilled at or before the Closing Time or if any such condition
is, or becomes, impossible to satisfy prior to the Closing Time, other than as a result of the failure of the Vendor to comply
with its obligations under this Agreement, then the Vendor in its sole discretion may, without limiting any rights or remedies
available to the Vendor at law or in equity, either:


 


		(a)	terminate this Agreement by notice to the Purchaser, as provided in Section 3.5; or



 


		(b)	waive compliance with any such condition without prejudice to its right of termination in the event
of non-fulfilment of any other condition.



 


	Section 3.3	Non-Waiver



 


No waiver of any condition
or other provisions, in whole or in part, shall constitute a waiver of any other condition or provision (whether or not similar)
nor shall such waiver constitute a continuing waiver unless otherwise expressly provided.


 


	Section 3.4	Disclosure and Extraordinary Claims



 


If the updated Schedules
to be delivered at Closing have revealed any facts, events or circumstances, that, unless arising as a result of actions taken
in the Ordinary Course, would, in the absence of disclosure of such facts, events or circumstances in the updated Schedules (if
Closing were to have occurred) otherwise have given rise (taking into account the provisions of this Agreement, including Section
7.6 and having applied the Basket, if relevant) to one or more claims for which the aggregate liability of the Vendor for Losses
is reasonably anticipated to be at least five hundred thousand dollars ($500,000) (an “Extraordinary Claim”);
notwithstanding anything else set forth in this Agreement, Vendor shall not be entitled to raise as a defense to a claim for Losses
brought by Purchaser in respect of an Extraordinary Claim, (x) the fact that Vendor disclosed the facts, events or circumstances
giving rise to such Extraordinary Claim in the updated Schedules at Closing, or (y) pursuant to the limitations in Section 5.1(5),
that the Purchaser otherwise had knowledge of the facts, events or circumstances giving rise to such Extraordinary Claim as a result
solely and exclusively of Vendor’s disclosure to the Purchaser of such facts, events or circumstances after the date hereof,
unless otherwise expressly agreed in writing between the Parties; provided that, if the aggregate amount of such Losses, upon the
final determination of the Losses associated with such Extraordinary Claim either through adjudication by a court of competent
jurisdiction or otherwise, would not have constituted an Extraordinary Claim, Vendor shall be entitled to raise those defenses
described in clauses (x) and (y) above to Purchaser’s claim for Losses in respect of such claims. For the avoidance of doubt,
nothing disclosed in the updated Schedules at Closing as a result of actions taken by the Vendor in the Ordinary Course during
the Interim Period shall be taken into consideration when determining whether there is an Extraordinary Claim.


 




     


     


    

 


	Section 3.5	Termination



 


This Agreement may be
terminated on or prior to the Closing Date:


 


		(a)	by the mutual written agreement of the Vendor and the Purchaser;



 


		(b)	by written notice from the Purchaser to the Vendor as permitted in Section 3.1(2) or Section 6.3;
or



 


		(c)	by written notice from the Vendor to the Purchaser as permitted in Section 3.2(2).



 


	Section 3.6	Effect of Termination



 


(1)          If
this Agreement is terminated:


 


		(a)	by the Vendor and/or by the Purchaser under Section 3.5, subject to Section 3.6(b), all further
obligations of the Parties under this Agreement shall terminate, except for the obligations under this Section 3.6, Section 6.2,
Section 9.2, and Section 9.3 which shall survive such termination; or



 


		(b)	by a Party under Section 3.5(b) or (c) and the right to terminate arose because of a breach of this
Agreement by the other Party (including a breach by the other Party resulting in a condition in favour of the terminating Party
failing to be satisfied), then, except as otherwise specifically provided for in this Agreement, the other Party shall remain fully
liable for any and all Losses sustained or incurred by the terminating Party directly as a result thereof.



 


Article
4 – REPRESENTATIONS AND

WARRANTIES OF THE VENDOR


 


The Vendor hereby represents
and warrants to the Purchaser, as at the date of this Agreement, as stated below and acknowledges that the Purchaser is relying
on the accuracy of each such representation and warranty in entering into this Agreement:


 


	Section 4.1	Incorporation and Organisation



 


The
Company is a corporation duly incorporated and organised under the Laws of Canada, the Company is a valid and subsisting corporation
in good standing under such Laws and the Company is licensed or qualified to transact business in each jurisdiction where the nature
of its activities makes such license or qualification necessary. The Vendor has made available to the Purchaser true and complete
copies in all material respects of the corporate charter and by-laws, or similar governing documents, of the Company.


 




     


     


    

 


	Section 4.2	No Bankruptcy



 


There has not been
filed any petition or application, or any proceeding commenced which has not been discharged in its entirety, by or against the
Company with respect to any assets of the Company under any Law relating to bankruptcy, reorganisation, fraudulent transfer, compromise,
arrangements, insolvency, readjustment of debt or creditors’ rights, and no assignment has been made by the Company for the
benefit of creditors.


 


	Section 4.3	Residence of Vendor and Principal Shareholder



 


Neither
the Vendor nor the Principal Shareholder is a non-resident of Canada within the meaning of the Tax Act.


 


	Section 4.4	No Subsidiaries



 


The
Company does not have any subsidiaries and does not hold shares or other ownership, equity or proprietary interests in any Person.


 


	Section 4.5	Due Authorisation and Enforceability of Obligations



 


(1)          The
Vendor has the capacity to own and sell its property and to enter into this Agreement, and all other agreements and instruments
to be executed by the Vendor contemplated herein, and to perform its obligations under this Agreement and under all such other
agreements and instruments. This Agreement, and each of the agreements to be executed and delivered by the Vendor pursuant to this
Agreement, has been duly executed and delivered by, and constitutes a legal, valid and binding obligation of the Vendor, enforceable
against the Vendor in accordance with its terms, subject to bankruptcy, insolvency and other Laws affecting the rights of creditors
generally and subject to the qualification that equitable remedies may only be granted in the discretion of a court of competent
jurisdiction.


 


(2)          The
execution and delivery of this Agreement does not, and the consummation by the Vendor of the transactions contemplated hereby,
and compliance with the terms hereof, have not and will not, conflict with, or result in any violation or breach of any provision
of: (i) any Contract to which the Vendor is a party, or (ii) any rights of any third party with respect to the acquisition of the
Purchased Assets, or (iii) any order, writ, injunction, decree, statute, rule or regulation applicable to the Vendor.


 


	Section 4.6	Actions Respecting Purchased Assets



 


There
are no Actions pending or, to the knowledge of the Vendor, threatened against or relating to the Vendor or with respect to or in
any manner affecting the ownership by the Vendor of the Purchased Assets or which would adversely affect the ability of the Vendor
to execute and deliver this Agreement and to consummate the sale of the Purchased Assets and the transaction contemplated hereby.


 




     


     


    

 


	Section 4.7	Approvals



 


All
requisite consents, licences, approvals, orders or authorisations of, provisions of notice to, or registrations, filings or declarations
with, any Governmental Authority required in order for the Vendor to enter into this Agreement and perform its obligations and
consummate the transactions contemplated hereunder have been obtained or made.


 


	Section 4.8	Corporate Records



 


The
corporate books of account, minute books, stock transfer books and stock register of the Company, true and correct copies of all
of which have been made available to the Purchaser, are complete and accurate and have been maintained in accordance with customary
business practices and all applicable Laws.


 


	Section 4.9	Title to Purchased Assets



 


The
Vendor is the sole and unconditional owner of the Purchased Assets, with good and valid title thereto, free and clear of all Encumbrances
other than Permitted Encumbrances. The Purchased Assets and the Excluded Assets together constitute all of the property and assets
(a) used or held for use in connection with the Business, and (b) necessary to operate the Business after Closing in the manner
in which the Business was conducted prior to Closing. 


 


	Section 4.10	Consents



 


Except
for the Consents listed in Schedule 4.10, no consent, license, approval, order or authorisation of, or provisions of notice to,
registration, filing or declaration with, any Person is required to be obtained or made by the Company in connection with the consummation
of the transactions contemplated by the Agreement and no consent by any other third party is necessary in connection with the consummation
of the transactions by the Vendor contemplated hereby. Schedule 4.10 identifies all Contracts under which the Company is required
to obtain consent to an assignment of such Contract or provide notice of any assignment thereof in connection with the transactions
contemplated hereby or the continuation of the Business by the Purchaser; where the absence of such Consent or the failure to give
such notice might reasonably be expected to have a material adverse effect on the operation of the Business.


 


	Section 4.11	No Default



 


The
Company is not in breach, default or violation of any term, condition or provision of its constating documents or by-laws.


 


	Section 4.12	No Other Agreements to Purchase



 


Except
for the Purchaser’s rights under this Agreement, no Person has any written or oral agreement, option or warrant, or any right
or privilege (whether by Law, pre-emptive or contractual) capable of becoming such for the purchase of any of the Purchased Assets,
other than in the Ordinary Course of the operation of the Business.


 




     


     


    

 


	Section 4.13	Business in Compliance with Law



 


The Company and all
aspects of the Business and its assets are and have been conducted in compliance with all Laws applicable to the Company. Except
as set forth in Schedule 4.13, the Company has not received any written notice from any Governmental Authority regarding any actual
or alleged violation of, or failure to comply in any respect with, any applicable Law.


 


	Section 4.14	Real Property and Leasehold Interests



 


The
Company is not and has never been at any time the owner (or the beneficial or registered owner, as applicable) of and the Company
has not agreed to acquire any real or immovable property (“Real Property”) or any interest in any Real Property, other
than as a lessee. The Company is not a party to any Lease or agreement in the nature of a Lease in respect of any Real Property,
whether as lessor or lessee, other than the leases described in Schedule 4.14, including the lease for the premises described in
Schedule 4.14 (collectively, the “Leasehold Premises”). Neither the Company nor, to the knowledge of the Vendor, any
other party thereto is in breach of any covenants, conditions or obligations contained in any Lease. The Vendor has provided a
true and correct copy of the Lease of the Leasehold Premises to the Purchaser. All buildings, structures, improvements, appurtenances,
fixtures and movables owned or leased by the Company, including without limitation those situated on the Leasehold Premises, are
in good operating condition, subject to normal wear and tear, and in a state of good maintenance and repair, are adequate and suitable
for the purposes for which they are currently being used.


 


	Section 4.15	Licenses



 


(1)          The
Company owns or holds all licenses, permits, franchises, approvals, consents, waivers, exemptions, authorisations, registrations,
classifications, certificates, notifications and similar rights and privileges (collectively “Licenses”), free
and clear of all Encumbrances other than Permitted Encumbrances and subject to no challenge, revocation, expiry, modification or
termination, which are required under all Laws or otherwise necessary or useful to the ownership of the Purchased Assets or the
conduct of the Business; all such Licenses are listed on Schedule 4.15, will remain with the Company upon the Closing of the transaction
herein contemplated, and the execution and consummation of the Agreement and the consummation of the transactions contemplated
herein or therein will not create any right of modification, limitation, termination or revocation on the part of any Person or
Governmental Authority granting any such Licenses; there exists no pending or, to the knowledge of the Vendor threatened, modification,
limitation, revocation or termination of any such License.


 


(2)          The
Licenses are sufficient and adequate in all material respects to permit the continued lawful conduct by the Company of the Business
in the manner now conducted and none of the Business operations of the Company are presently being conducted in a manner that violates
in any respect any of the terms or conditions under which any License was granted.


 


(3)          The
Licenses have been duly obtained, are valid and are in full force and effect and the Company is in full compliance with all terms
and conditions of all such Licenses and has not received any notice of the revocation or limitation of any of the Licenses.


 




     


     


    

 


	Section 4.16	Litigation



 


Except
as disclosed in Schedule 4.16, there are no Actions pending or, to the knowledge of the Vendor, threatened against the Company.
To the knowledge of the Vendor, the Company is not the subject of any current or pending investigation or proceedings by any Governmental
Authority. None of the assets of the Company, nor its business practices, is the subject of any judgement, order, writ, or injunction
of any Governmental Authority. The Company does not have any Liability, including in respect of legal and other professional fees,
on account of defective Products (including, to the knowledge of the Vendor, Accrued Liability on account of Product warranties).


 


	Section 4.17	Regulatory Matters



 


(1)          Except
as set forth in Schedule 4.17, neither the Vendor nor the Company have received any information (in any form or of any kind) from
any Governmental Authority with jurisdiction over the importation, marketing, sale, use, distribution, handling and control, safety,
efficacy, reliability, labelling or manufacturing of the Products which would reasonably be expected to lead to the denial of the
sale or marketing of the Products.


 


(2)          Except
as set forth in Schedule 4.17, for the last five (5) years, neither the Vendor nor the Company have voluntarily or involuntarily
initiated, conducted or issued, or caused to be initiated, conducted or issued, any recall, field alerts, field corrections, market
withdrawal or replacement, safety alert, warning, “dear doctor” letter, investigator notice, safety alert or other
notice or action relating to an alleged lack of safety, efficacy or regulatory compliance of any Product.


 


(3)          As
of the date hereof, except as set forth in Schedule 4.17, there are no facts or circumstances relating to the Company that would
reasonably be expected to result in (i) the recall, market withdrawal or replacement of any Product sold or intended to be sold
by the Company, (ii) a change in the marketing classification or a material change in the labelling of any such Products, or (iii)
a termination or suspension of the marketing of such Products.


 


	Section 4.18	Financial Statements



 


		(1)	The Financial Statements have been prepared in accordance with ASPE applied on a basis consistent
with that of the preceding period and present fairly:



 


		(a)	all of the assets, liabilities and financial position of the Company as at September 30, 2014;
and



 


		(b)	the sales, earnings, results of operation and changes in financial position of the Company for
the 12 month period ended September 30, 2014.



 




     


     


    

 


	Section 4.19	Absence of Undisclosed Liabilities



 


(1)          The
Company has not incurred any liabilities or obligations (whether accrued, absolute, contingent or otherwise), which continue to
be outstanding, except (a) as disclosed in the Financial Statements, or (b) as disclosed on Schedule 4.19.


 


(2)          Except
as set forth on Schedule 4.19, the Company does not have any Indebtedness.


 


	Section 4.20	Material Contracts



 


(1)          Schedule
4.20 annexed hereto is a true and complete list as at the date hereof of all Contracts, each having no less than a total aggregate
annual value of $50,000.00, to be transferred to the Purchaser with the Purchased Assets and to which the Company is a party or
by which the Company or the Purchased Assets are bound (“Material Contracts”).


 


(2)          Except
as set forth on Schedule 4.20, the Company and, to the knowledge of the Vendor, each of the other parties thereto has performed
all obligations to be performed under the Material Contracts, and neither the Company nor, to the knowledge of the Vendor, any
other party thereto is in material respects in default under any provision of any Material Contracts. The Company has not received
any written notice alleging it is in breach or default of any provision of any Material Contracts. No event (including the consummation
of the transactions contemplated by this Agreement) has occurred which constitutes, or which with the passage of time or the giving
of notice or both will constitute, a breach or default under any provision of any Material Contract by the Company, or to the knowledge
of the Vendor, any other party, or which would permit the acceleration or termination of any obligation of any party thereto or
the creation of any Encumbrance upon any asset of the Company or result in a loss of rights of the Company or which would give
rise to any of the foregoing upon the giving of notice or lapse of time or both. The Company has not received any written notice
from any other party to any Material Contract that such person intends to terminate any Material Contract. Except as disclosed
in Schedule 4.10, no consent of any party to any Material Contract is required for the consummation of the transactions contemplated
by the Agreements.


 


(3)          The
Vendor has made available to the Purchaser a (i) correct and complete copy of each Material Contract (as amended through the date
hereof) and (ii) written description of the material terms of any Material Contract that is not set forth in a written document,
in each case prior to the date of this Agreement. Each Material Contract is valid and binding on the Company, and in full force
and effect; subject to the qualification that equitable remedies may only be granted in the discretion of a court of competent
jurisdiction.


 


	Section 4.21	Commission Arrangements



 


The Company is not
a party to any Contracts or other arrangements to pay commissions or other form of variable compensation based on sales, purchases
or other transactions to any Employees, third parties or persons other than those Contracts or other arrangements set forth on
Schedule 4.21 annexed hereto.


 




     


     


    

 


	Section 4.22	Suppliers and Customers



 


Schedule 4.22 sets
out the ten (10) largest customers and eight (8) largest suppliers of the Company, in terms of volume sales and purchases, collectively,
for the fiscal year 2014 and for the eleven (11) month period ending August 31, 2015 and sets out the approximate volume of sales
and purchases. No supplier or customer of the Company listed on Schedule 4.22 has cancelled or otherwise terminated, or, to the
knowledge of the Vendor, threatened in writing to cancel or otherwise terminate, its relationship with the Company or has during
the last twelve (12) months decreased materially, or, to the knowledge of the Vendor and the Company, threatened to decrease or
limit materially, its services, supplies or materials to the Company. To the knowledge of the Vendor and the Company, no customer
or supplier listed in Schedule 4.22 intends to cease dealing with the Company, or intends to alter in any material respect the
amount of such customer’s or supplier’s dealings with the Company.


 


	Section 4.23	Non-Arm’s Length Transactions



 


Other than as disclosed
in Schedule 4.23, neither the Vendor nor any party with whom the Vendor does not act at arm’s length (including without limitation
any director, officer, shareholder of the Company or any member of the immediate family of any such individual or any of their
respective Affiliates): (i) has any interest of any nature in any property or assets, tangible or intangible, which are or have
been used, within the prior twelve (12) months, by the Company in connection with the conduct of its business, (ii) is a party
to any Contract or other business arrangement with the Company, or (iii) has any claim (including any claim for indemnification),
cause of action or right accrued, contingent or otherwise, against the Company.


 


	Section 4.24	Insurance



 


(1)          Schedule
4.24 sets forth a complete list of all policies of fire, liability and other forms of insurance held by the Company as of the date
hereof. The insurance policies maintained by the Company are appropriate to its operations, property and assets, in such amounts
and against such risks as are customarily carried and insured against by owners of comparable businesses, properties and assets
in the industry in which the Company operates. All such policies are valid, outstanding and in full force and effect, as to which
premiums have been paid currently. The Company is not in default under any provision of any such policy of insurance and has not
received notice of cancellation or non-renewal of any such insurance and no misstatement or misrepresentation has been made by
the Company in any application for any policy of insurance. There is no claim by the Company pending under any of such policies
as to which coverage has been questioned, denied or disputed in any manner by the underwriters or carriers of such policies. The
Vendor has made available to the Purchaser a correct and complete copy of each of the policies held by the Company set forth in
Schedule 4.24.


 


	Section 4.25	Intellectual Property



 


(1)          The
material Intellectual Property owned by, licensed to or by, or otherwise used by the Company is listed and described in Schedule
4.25 annexed hereto (collectively, the “Business IP”), which schedule sets forth, where appropriate, an
identification of each such item of Business IP, the jurisdiction and date of any registration thereof or application therefore
and the serial or registration number thereof.


 




     


     


    

 


(2)          The
Company has the right to use all Business IP as currently used by it.


 


(3)          The
Company has taken reasonable security measures to protect the secrecy, confidentiality and value of its trade secrets.


 


(4)          Except
as identified in Schedule 4.25, the Company has not granted any license to use the Business IP.


 


(5)          Except
for Intellectual Property that is licensed by the Company and identified as such in Schedule 4.25, the Company is the registered
and legal owner of all registered Business IP and the legal owner of all other Business IP, in all cases with good and marketable
title, unencumbered, and subject to no pending challenge, revocation, expiry or termination.


 


(6)          Except
as identified in Schedule 4.25, the Company is not required to pay royalties, fees or other consideration to any other person with
respect to the use of any Intellectual Property, with the exception of software license fees for generally commercially available,
non-custom, off-the-shelf software application programs, which have been paid in full.


 


(7)          There
are no agreements, judgements, decrees or orders restricting or limiting the use by the Company of any of the Business IP and the
operation of the Business of the Company does not violate, breach or infringe any patents, copyrights, trade names, trademarks,
industrial designs, licenses, or other Intellectual Property held by others and, to the knowledge of the Vendor, there is not any
alleged infringement, breach or violation thereof or any Action pertaining thereto.


 


(8)          All
of the Business IP listed on Schedule 4.25 as registered or filed has been duly registered or filed in the appropriate governmental
office or with the appropriate Governmental Authority, to the extent that any such registration is required by Law and the Company
has paid all fees due prior to the date hereof that are necessary to obtain or maintain in force any of the Business IP or the
exclusive rights thereto. No event has occurred during the registration or filing of, or during any other proceeding relating to,
the Business IP that is registered that would make invalid or unenforceable, or negate the right to issuance or use of, any of
the Business IP and there has been no refusal or threat of refusal to register any trademark or trade name on the basis that it
is not protectable or confusingly similar to another mark or name.


 


(9)          Except
as identified in Schedule 4.25, there have been no claims and to the knowledge of the Vendor, there is no basis for any claim challenging
the scope, validity or enforceability of any of the registered Business IP or applications for the registration thereof of the
Company. There have not been, nor are there, any infringements or, to the knowledge of the Vendor, threats of infringements by
the Company or any asserted claims of third parties against the Company in respect of infringements or misappropriation of any
intellectual property rights of any kind, nor are there any infringements of any of the Business IP, nor any asserted or unasserted
claims by the Company contesting or challenging the right, title or interest of any other person in any of the Business IP.


 




     


     


    

 


(10)          The
Company does not use any software, other than generally commercially available, non-custom, off-the-shelf software application
programs and that does not require entering into a license agreement other than a “shrink-wrap” or “click-wrap”
license agreement. The Company has not copied nor used any licensed software in violation of the applicable license or otherwise
violated any of its agreements or the rights of any other person with respect thereto.


 


	Section 4.26	Employee Indebtedness



 


No director, former
director, officer, former officer, shareholder or employee of the Company or any person not dealing at arm’s length (within
the meaning of the Tax Act) with any such person is indebted to the Company.


 


	Section 4.27	Tax Matters



 


Except as specifically disclosed in Schedule
4.27:


 


(1)          All
Tax Returns of the Company for all Tax periods ending before the Closing Date have been duly filed on a timely basis with the appropriate
Taxing Authority and are true, complete and correct and contain no misrepresentations. None of the Purchased Assets is subject
to any Encumbrance (other than a Permitted Encumbrance) for failure to file when due any required Tax Return.


 


(2)          All
Taxes required to have been paid, deducted, withheld or remitted by the Company on or before the Closing Date have been so paid,
deducted, withheld or remitted. Without limiting the foregoing, the Company has withheld from each payment made to any Person,
including any of its present or former employees, officers or directors and, in respect of other payments, to all Persons who are
or are deemed to be non-residents of Canada for purposes of the Tax Act all amounts required by applicable Law to be withheld,
and has remitted such withheld amounts within the prescribed periods to the appropriate Taxing Authority. The Company has remitted
all Canada Pension Plan contributions, provincial pension plan contributions, employment insurance premiums, employer health taxes
and other Taxes payable by it in respect of its present or former employees, officers or directors to the proper Taxing Authority
within the time required under applicable Law. The Company has charged, collected and remitted on a timely basis all Taxes as required
under applicable Law on any sale, supply or delivery whatsoever, made by it.


 


(3)          The
Company has no liability, obligation or commitment for the payment of Taxes, except those as are disclosed in the Financial Statements
or such Taxes not yet due as have arisen since the date of the Financial Statements in the usual and Ordinary Course and for which
adequate provision in the accounts of the Company have been made. The Company is not a party to or bound by and does not have any
obligations under, any Tax sharing agreement or similar contract or arrangement.


 


(4)          No
Tax Return of the Company is now under audit, investigation or examination or subject to any dispute, objection or appeal by or
with any Taxing Authority and there are no proceedings now pending or, to the knowledge of the Vendor, threatened against the Company
with respect to any Tax, and there are no matters under discussion with any Taxing Authority relating to any Tax.


 




     


     


    

 


(5)          There
are no agreements, waivers or other arrangements providing for an extension of time with respect to the filing of any Tax Return
by, or the assessment, reassessment or collection of any Tax or deficiency of any nature against the Company or with respect to
any Tax Return.


 


(6)          Other
than those agreements and arrangements described in Schedule 4.27(6), the Company has not made, prepared and/or filed any elections,
designations or similar filings relating to Taxes or entered into any agreement or other arrangement in respect of Taxes or Tax
Returns that has effect for any period ending after the Closing Date.


 


(7)          The
Company is registered for goods and sales tax/harmonized sales tax purposes under Part IX of the Excise Tax Act (Canada)
and its registration number is 841-660-160.


 


(8)          Neither
the Company nor its directors or officers are aware of any overly aggressive or improper treatment of income and expenses in filing
earlier Tax returns. The Company has not claimed a deduction with respect to an outlay or expense that may be considered unreasonable
under the circumstances. The Company has not, for the purposes of the Excise Tax Act (Canada), claimed any input tax credits
or, for the purposes of An Act respecting the Québec Sales Tax (Québec), claimed any input tax refunds to
which it is not entitled.


 


(9)          The
Company is not, or has not been, required to file any Tax Returns with, or to pay any Taxes to, any Taxing Authority located in
any jurisdiction outside Canada.


 


(10)        Schedule
4.27(10) accurately sets out the status of the following Tax accounts of the Company as of the date of the Financial Statements:


 


		(a)	the adjusted cost base of the Company’s capital properties;



 


		(b)	the Company’s capital dividend account;



 


		(c)	the cost of the Company’s depreciable properties for capital cost allowance purposes;



 


		(d)	the capital cost allowance taken on each class of the Company’s depreciable property;



 


		(e)	the undepreciated capital cost of each class of the Company’s depreciable property;



 


		(f)	the Company’s cumulative eligible capital account;



 


		(g)	the Company’s refundable dividend tax on hand;



 


		(h)	the Company’s non-capital losses and net capital losses;



 


		(i)	the Company’s investment tax credits; and



 




     


     


    

 


		(j)	the input tax credits, as defined in the Excise Tax Act (Canada) for the purposes of the
GST.



 


(11)       The
Inventory of the Company has been valued for Tax purposes at the lower of cost or net realisable value.


 


(12)       The
fair market value of all depreciable property of the Company is at least the amount of the undepreciated capital cost therefor
recorded on its books.


 


(13)       The
paid up capital of the Company for income tax purposes equals its paid up capital under corporate Law.


 


(14)       Except
as set forth in Schedule 4.27(14), the Company has:


 


		(a)	not: (A) acquired property from a non-arm’s length Person, within the meaning of the Tax
Act, for consideration, the value of which is less than the fair market value of the property acquired in circumstances which could
subject it to a liability under section 160 of the Tax Act; or (B) made any election under section 85 of the Tax Act (or equivalent
provision under provincial Law) with respect to the acquisition or disposition of any property;



 


		(b)	not made any election under subsection 83(2) of the Tax Act (or equivalent provision under provincial
Law) in excess of its capital dividend account;



 


		(c)	not made any eligible dividend designation under the Tax Act (or equivalent provision under provincial
Law) in excess of its general rate income pool;



 


		(d)	made all elections or designations required to be made under the Tax Act (or equivalent
provincial Law) in connection with any distributions and all such elections or designations were true and correct and in prescribed
form and were made within the prescribed time periods;



 


		(e)	not made any invalid, late or excess designations under the Scientific Research and Experimental
Development Tax Credit Provisions of the Tax Act; and



 


		(f)	not made or been a party to any election, including but not limited to Sections 150(1), 156(1),
227(1) or 273(1) of the Excise Tax Act (Canada) or An Act respecting the Québec Sales Tax.



 


(15)       The
Company does not have any net capital losses as of the date of the Financial Statements, nor has it discontinued carrying on any
business in respect of which any non-capital losses were incurred.


 


(16)       There
has never been a change of control of the Company for the purposes of the Tax Act.


 




     


     


    

 


(17)        Any
interest paid, payable or otherwise accruing on any interest-bearing debt of the Company is deductible (and to the extent that
such debt exists on closing will continue to be deductible) in computing its income under the Tax Act and if any interest were
paid or payable on any non-interest bearing debt of the Company, the amount of such interest would be deductible in computing its
income under the Tax Act and to the extent such debts exist on closing, the interest thereon will continue to be deductible under
the Tax Act.


 


(18)        There
are no amounts outstanding and unpaid for which the Company has previously claimed a deduction under the Tax Act.


 


(19)        There
are no circumstances which exist and would result in, or which have existed and resulted in, any of the Sections 80 to 80.04 or
Section 78, of the Tax Act applying to the Company.


 


(20)        The
Company has not claimed any reserve under any one or more of subparagraph 40(1)(a)(iii) or subparagraphs 20(1)(m) or 20(1)(n) of
the Tax Act if any such amount could be included in the income of the Company for a period ending after Closing.


 


(21)        The
Company has never declared or paid a dividend to which Tax under Part VI.1 of the Tax Act applies.


 


	Section 4.28	No Broker



 


Except as set forth
on Schedule 4.28, neither the Company, nor any director, officer, employee or agent of the Company has employed or has incurred
any obligation or liability for broker’s or finder’s fees or other payment with respect to the Agreement or the transactions
contemplated hereby.


 


	Section 4.29	Accounts and Records



 


The Company has maintained
up to and including the date hereof, accurate and complete books of account and financial records fairly and accurately reflecting
in all material respects, on a basis consistent with past periods and throughout the periods involved, (i) the financial position
of the Company and (ii) all material transactions of the Company, including all transactions between the Company and the Vendor
and such books of account and financial records have been maintained in accordance with ASPE consistently applied, and all such
books and records shall remain with the Company at the Closing.


 


	Section 4.30	Products, Product Registrations and Operational Permits



 


		(1)	Schedule 4.30 sets out: (i) a complete list of the Products; (ii) all Product Registrations and
Operational Permits issued to the Company on or prior to the date of this Agreement for Products that remain on the market on the
date of this Agreement; and (iii) all applications for Product Registrations and Operational Permits made by the Company that are
either under preparation or pending on the date of this Agreement.



 




     


     


    

 


		(2)	The Company holds or has the right to use all Product Registrations and Operational Permits required
for the conduct of the Business as presently conducted. All of the Product Registrations and Operational Permits are in full force
and effect and, to the knowledge of the Vendor, have been duly and validly issued. The Company has, in all material respects, fulfilled
and performed, and is performing, all of its obligations with respect to the Product Registrations and Operational Permits, and,
to the knowledge of the Vendor, no event has occurred which allows, or after notice or lapse of time would allow, revocation, suspension
or termination thereof or which would result in any other material impairment of the rights of the holder of any Product Registration
or Operational Permit.



 


		(3)	All reports, documents, claims and notices required to be filed, maintained or furnished to Health
Canada or any other Governmental Authority by the Company have been so filed, maintained or furnished and were complete and correct
in all material respects.



 


		(4)	To the knowledge of the Vendor, each Product is being or has been developed, manufactured, tested,
imported, distributed and marketed in compliance in all material respects with all applicable Laws, including those relating to
investigational use, premarket clearance or marketing approval, good manufacturing practices, good clinical practices, good laboratory
practices, labelling, advertising, record keeping, filing of reports, and security. To the knowledge of the Vendor, all operations
pertaining to the manufacturing of the Products have been conducted in compliance with Good Manufacturing Practices under the applicable
provisions of the Food and Drugs Act (Canada) and the Food and Drug Regulations.



 


		(5)	The Vendor is the sole and exclusive owner of the Product Registrations and Operational Permits
and has not granted a right of reference with respect to them to any Third Party.



 


		(6)	For the last five (5) years, no Actions related to Product liability have been initiated against
the Company and, to the knowledge of the Vendor; no such Actions have been threatened or filed against the Company relating to
any of the Products. There is no judgment, order, injunction, decision or award outstanding against the Company relating to any
such Action on account of any of the Products.



 


	Section 4.31	Warranties and Product Liability



 


Attached as Schedule
4.31 hereto is a description of each express product warranty, if any, given by the Company with respect to Products sold by the
Company during the past twelve (12) months and a true copy of each such warranty has been furnished or made available by
the Vendor to the Purchaser prior to the date hereof. There are no pending, or to the knowledge of the Vendor, threatened Actions
or other proceedings under any product warranty. Within the last twelve (12) months, except for product warranty replacements and
refunds arising in the Ordinary Course, the Company has not incurred any material Liability by reason of any express or implied
warranty with respect to any Products sold by or on behalf of the Company. There is no and there has not been any Action or other
proceeding or investigation by or before any Governmental Authority pending or, to the knowledge of the Vendor, threatened against
or involving the Company relating to any product alleged to have been sold by on behalf the Company and alleged to have been defective,
or improperly designed or manufactured, and, to the knowledge of the Vendor, there is not any basis for any such action, proceeding
or investigation.


 




     


     


    

 


	Section 4.32	Return of Merchandise



 


The Company does not
have any Products in the possession of its customers on consignment or on a similar basis. The Company has not made or participated
in any full or partial recall or stock recovery of any of the Products, whether on a voluntary basis or pursuant to a notice or
request received from any Governmental Authority and has not received any written notices or other communication from any Governmental
Authority relating to the possible recall or stock recovery of any of the Products. No such recall or stock recovery is being considered
by the Company, and to the knowledge of the Vendor, no such recall or stock recovery is being considered or has been requested
or ordered by any customers or customer group.


 


	Section 4.33	Environmental Matters



 


(1)          The
Company: (i) is in compliance in all material respects with all applicable Environmental Laws, and (ii) has obtained, and is in
compliance in all material respects with all permits, licenses, authorisations, registrations and other governmental consents required
by applicable Environmental Laws (collectively, the “Environmental Permits”), and has made all appropriate
filings for issuance or renewal of such Environmental Permits.


 


(2)          There
is no contamination of, and there have been no releases or, to the knowledge of the Vendor, threatened releases of Hazardous Materials
at the Leasehold Premises where the Company carries out its principal business; in each case, that (i) would require notification
to Governmental Authorities, investigation and/or remediation pursuant to any Environmental Laws or (ii) would be reasonably likely
to give rise to material liabilities pursuant to any Environmental Laws.


 


(3)          The
Company has not used any waste disposal site, or otherwise disposed of, transported, or arranged for the transportation of, any
Hazardous Materials to any place or location in violation of any Environmental Laws.


 


(4)          The
Vendor has delivered, or made available, to the Purchaser true and complete copies of any environmental site assessments, audits,
reports, studies, analyses, tests, or monitoring in its possession or initiated by the Company pertaining to Environmental Law.


 


	Section 4.34	Absence of Changes and Unusual Transactions



 


(1)          Except
as set forth on Schedule 4.34, from the date of the Financial Statements until the date hereof, the Company has: (i) conducted
its business in the Ordinary Course in the manner in which such business has heretofore been conducted; (ii) not incurred any Liability
whatsoever, secured or unsecured, direct or indirect, other than Accrued Liabilities in the Ordinary Course and which are not for
borrowed money, none of which is material; (iii) not entered into any Contracts whatsoever, other than in the Ordinary Course of
its Business; (iv) not made or committed to make any capital expenditures in excess of an aggregate of $150,000 or $50,000 in respect
of any particular item, and (v) not amended nor terminated nor suffered the amendment nor termination of, nor given nor received
any notice of any proposed amendment or termination of, any Contract, except in the Ordinary Course; and without limiting the generality
of this Section 4.34(1), has: 


 




     


     


    

 


		(a)	not sold, leased, mortgaged or otherwise encumbered or suffered or permitted any Encumbrance on
or disposed of any of its assets, whether voluntarily or by operation of Law, or committed to do any of the foregoing, except for
the sale of products in the ordinary and usual conduct and course of its business consistent with past practice;



 


		(b)	not cancelled, waived or released or otherwise compromised any Indebtedness or claim or any right
of significant nature (or committed to do any of the foregoing);



 


		(c)	not suffered any damage, destruction or loss, whether or not covered by insurance, which is likely
to materially and adversely affect its property, assets or business;



 


		(d)	not incurred any Liabilities or expenses out of the Ordinary Course or effected any material changes
in the management or operation of its business (or committed to do any of the foregoing);



 


		(e)	not changed in any material manner the terms of engagement nor increased the wages, salary, rate
of bonus or commission or other basis of remuneration of any Employee, nor paid any bonus or similar payment (or committed to do
any of the foregoing);



 


		(f)	not encountered any labour union organising activity or had any actual or, to the knowledge of
the Vendor, threatened employee strikes, work stoppages, slowdowns or lockouts;



 


		(g)	not adopted or amended any Employee Plan (or committed to do any of the foregoing);



 


		(h)	not adopted or changed any accounting methods, principles, practices or policies, nor varied any
insurance coverage (or committed to do any of the foregoing);



 


		(i)	not disposed of anything to a person with whom it was not dealing at arm’s length for proceeds
of disposition less than the fair market value thereof;



 


		(j)	not settled or compromised any pending or threatened Action;



 


		(k)	not failed to invoice its customers and collect its Accounts Receivable, pay its Taxes and other
Liabilities when due and pay or perform its other material obligations when due, in each case in the usual course and conduct of
its businesses consistent with past practice;



 


		(l)	not entered into any Contract which purports to grant exclusive rights to any person;



 




     


     


    

 


		(m)	not entered into any Contract that purports to limit, curtail or restrict the kinds of businesses
in which it may conduct its business, or the persons with whom it can compete or to whom it can sell products or deliver services;



 


		(n)	not incurred or suffered to exist any Indebtedness except for working capital and capital expenditure
borrowings in the usual course and conduct of its businesses consistent with past practice; and



 


		(o)	not authorised, agreed resolved or consented to any of the foregoing.



 


Article
5 – Representations and Warranties of the Purchaser


 


The Purchaser for itself represents and
warrants to the Vendor, as at the date of this Agreement and as at the Closing Date, as stated below and acknowledges that the
Vendor is relying on the accuracy of each such representations and warranties in entering into this Agreement and completing the
sale of the Purchased Assets.


 


	Section 5.1	Representations and Warranties of the Purchaser



 


(1)          Incorporation
and Corporate Power. The Purchaser is a corporation duly incorporated and organised under the existing under the Laws of Delaware,
the Purchaser is a valid and subsisting corporation in good standing under such Laws and the Purchaser is licensed or qualified
to transact business in each jurisdiction where the nature of its activities makes such license or qualification necessary. The
Purchaser has made available to the Vendor true and complete copies in all material respects of the corporate charter and by-laws,
or similar governing documents, of the Purchaser.


 


(2)          Due
Authorisation and Enforceability of Obligations.


 


		(a)	The Purchaser has the authority to execute and deliver the Agreement, to perform its obligations
under the Agreement and to consummate the transactions contemplated hereby. This Agreement has been duly executed and delivered
by the Purchaser and constitutes the valid and binding obligation of Purchaser, enforceable against Purchaser, as applicable, in
accordance with its terms, subject to bankruptcy, insolvency and other Laws affecting the rights of creditors generally and subject
to the qualification that equitable remedies may only be granted in the discretion of a court of competent jurisdiction.



 


		(b)	The execution and delivery of this Agreement does not, and the consummation by Purchaser of the
transactions contemplated hereby, and compliance with the terms hereof, have not and will not, conflict with, or result in any
violation or breach of any provision of: (i) any Contract to which the Purchaser is a party, or (ii) any order, writ, injunction,
decree, statute, rule or regulation applicable to the Purchaser.



 


(3)          Required
Authorisations. All requisite consents, licences, approvals, orders or authorisations of, provisions of notice to, or registrations,
filings or declarations with, any Governmental Authority required in order for the Purchaser to enter into this Agreement and perform
its obligations and consummate the transactions contemplated hereunder have been obtained or made.


 




     


     


    

 


(4)          No
Broker. Except as set forth on Schedule 5.1(4), neither the Purchaser, nor any director, officer, employee or agent of the
Purchaser has employed or has incurred any obligation or liability for broker’s or finder’s fees or other payment with
respect to the Agreement or the transactions contemplated hereby.


 


(5)          No
Awareness of Claims; Disclaimer. Neither the Purchaser nor any of its Affiliates are aware of any fact, matter or circumstance
which might entitle the Purchaser to make a claim against the Vendor for breach of the representations, warranties or covenants
under this Agreement. For the purpose of this Section 5.1(5), (i) a reference to Purchaser’s awareness is deemed to include
the knowledge, information and belief which Purchaser would have if Purchaser had made all reasonable enquiries and includes, without
limitation, the information included in the Schedules to this Agreement, and (ii) Vendor shall bear the burden of proof in relation
to Purchaser’s awareness, if relying on this provision in defence of a Third Party Claim by Purchaser under this Agreement.
Any claims Purchaser may have for breach of representation or warranty shall be based solely on the representations and warranties
of Vendor expressly set forth in this Agreement, and the certificates delivered pursuant hereto. EXCEPT AS EXPRESSLY STATED HEREIN,
ALL WARRANTIES OF MERCHANTABILITY AND FITNESS FOR ANY PARTICULAR PURPOSE, AND ALL OTHER WARRANTIES ARISING UNDER THE UNITED STATES
UNIFORM COMMERCIAL CODE (OR SIMILAR APPLICABLE LAWS IN ANY JURISDICTION WITH COMPETENT AUTHORITY), ARE HEREBY DISCLAIMED BY THE
VENDOR AND WAIVED BY THE PURCHASER.


 


Article
6– COVENANTS


 


	Section 6.1	Investigation



 


During
the Interim Period, the Vendor shall give, or cause to be given to the Purchaser full access during normal business hours to the
Business and the Purchased Assets, including the Books and Records and the Contracts, to conduct such investigations, inspections,
surveys or tests thereof and of the financial and legal condition of the Business as the Purchaser deems necessary or desirable
to familiarise itself with such properties, assets and other matters.


 


	Section 6.2	Confidentiality



 


(1)          Information
to be Confidential. Each Recipient shall treat confidentially and not disclose, and shall cause each of
its Representatives to treat confidentially and not disclose, other than as expressly contemplated by this Agreement, any Confidential
Information of the Discloser.


 


(2)          Use
of Confidential Information.  A Recipient may disclose Confidential Information only to those of
its Representatives who need to know such Confidential Information for the purpose of implementing the transaction contemplated
by this Agreement. No Recipient shall use, nor permit its Representatives to use, Confidential Information for any other purpose
nor in any way that is, directly or indirectly, detrimental to the applicable Discloser.


 




     


     


    

 


(3)          Return
or Destruction. Following the termination of this Agreement in accordance with the provisions of this
Agreement, each Recipient shall (and shall cause each of its Representatives to) (a) return promptly to the Discloser all physical
copies of the Confidential Information of the Discloser, excluding notes, then in such Recipient’s possession or in the possession
of its Representatives, (b) destroy all (i) electronic copies of such Confidential Information, and (ii) notes (including electronic
copies thereof) prepared by such Recipient or any of its Representatives, in a manner that ensures the same may not be retrieved
or undeleted by such Recipient or any of its Representatives, and (c) deliver to the Discloser a certificate executed by one
of the Recipient’s duly authorized senior officers indicating that the requirements of this Section 6.2(3) have been satisfied
in full.


 


(4)          Personal
Information. After the Closing, the Purchaser shall not, and shall cause its Representatives not to, use
or disclose information about identifiable individuals, as defined in applicable Laws in Canada relating to privacy, other than
for the purpose of carrying on the Business or for purposes other than those for which such information was collected by the Vendor,
except with the consent of the individuals to whom such information relates or as otherwise required by applicable Law. If the
Vendor or the Purchaser terminates this Agreement as provided herein, the Purchaser shall promptly deliver to the Vendor all information
about identifiable individuals, as defined in applicable Laws in Canada relating to privacy, in its possession or in the possession
of any of its Representatives, including all copies, reproductions, summaries or extracts thereof.


 


	Section 6.3	Risk of Loss



 


The Purchased Assets
shall be at the risk of the Vendor until Closing. If before the Closing all or any substantial portion of the Purchased Assets
are lost, damaged or destroyed or are expropriated or seized by any Governmental Authority or any other Person in accordance with
applicable Law or if notice of any such expropriation or seizure shall have been given in accordance with applicable Law, the Purchaser,
in its sole discretion, shall have the option, exercisable by notice to the Vendor given prior to the Closing Time:


 


		(a)	to terminate this Agreement; or



 


		(b)	to complete the transactions contemplated by this Agreement and require the Vendor to assign to
the Purchaser the proceeds of any insurance payable as a result of the occurrence of such loss, damage, destruction, expropriation
or seizure.



 


	Section 6.4	Action During Interim Period



 


(1)          Operate
in Ordinary Course. During the Interim Period, the Vendor shall operate the Business in the Ordinary Course
in compliance with applicable Law and the terms and conditions of all Contracts relating to the Business, and in a manner that
maintains relations with Employees and the suppliers, customers and landlords of the Vendor in accordance with past custom and
practice.


 




     


     


    

 


(2)          Negative
Covenants. During the Interim Period, neither the Vendor nor the Purchaser shall take any action
that would cause any of the representations and warranties in Article 4 or Article 5, respectively, to become untrue on the Closing
Date.


 


(3)          Third
Party Approaches. If the Vendor receives any proposal from any Person during the Interim Period for the
purchase of the Business or any of the Purchased Assets or any other business combination transaction involving the Vendor or any
request for information about the Vendor, the Business or any of the Purchased Assets, it shall immediately notify the Purchaser
of such proposal or request and the terms thereof. The Vendor shall not, and shall ensure that its Representatives do not, during
the Interim Period, solicit or pursue any such proposal or provide any information concerning the Vendor, the Business or any of
the Purchased Assets to any Person other than the Purchaser or its Representatives.


 


(4)          Notice
of Certain Matters. During the Interim Period, the each Party shall promptly upon becoming aware, give
written notice to the other Party of: (a) the occurrence of any event that causes any representation and warranty of the notifying
Party contained in this Agreement to be untrue or inaccurate, and (b) any failure of the notifying Party to comply with or satisfy
any covenant, condition or agreement to be complied with or satisfied by it hereunder; provided, however, that the delivery of
any notice pursuant to this Section 6.4(4) shall not limit or otherwise affect any remedies available to the other Party.


 


	Section 6.5	Consents



 


The Vendor shall use
commercially reasonable efforts to obtain all Consents at or prior to the Closing Time.


 


Article
7 – INDEMNIFICATION


 


	Section 7.1	Survival



 


Unless otherwise expressly
set forth in this Agreement, all provisions of this Agreement and of any other agreement, certificate or instrument delivered pursuant
to this Agreement, other than the conditions in Article 3, shall not merge on Closing but shall survive the execution, delivery
and performance of this Agreement, the Closing and the execution and delivery of any transfer documents or other documents of title
to the Purchased Assets and all other agreements, certificates and instruments delivered pursuant to this Agreement and the payment
of the consideration for the Purchased Assets.


 


	Section 7.2	Indemnification by the Vendor



 


The Vendor shall indemnify
and save harmless each of the Purchaser, its Affiliates and their respective Representatives and shareholders (collectively referred
to as the “Purchaser Indemnified Parties”), net of any fees, costs or expenses reasonably incurred by Purchaser
Indemnifying Parties in seeking indemnification hereunder, from and against all Losses, whether or not arising due to third party
claims that may be made or brought against the Purchaser Indemnified Parties, or that they may suffer or incur, directly or indirectly,
as a result of or in connection with or relating to:


 




     


     


    

 


		(a)	any misrepresentation or any incorrectness in or breach of any representation or warranty of the
Vendor contained in this Agreement or in any certificate or other document furnished by or on behalf of such Vendor pursuant to
this Agreement;



 


		(b)	any non-fulfilment or breach of any covenant or agreement on the part of the Purchaser contained
in this Agreement or in any certificate or other document furnished by or on behalf of the Purchaser pursuant to this Agreement;



 


		(c)	defects or deficiencies in any Product manufactured or distributed by the Business prior to the
Closing Date; and



 


		(d)	the Excluded Assets and Excluded Liabilities, except to the extent such Excluded Asset or Excluded
Liability is acquired or assumed by an Affiliate of the Purchaser.



 


For greater certainty
and without limiting the generality of the provisions of Section 7.2(a) and (b), the indemnity provided for in Section 7.2(c) shall
extend to any Losses arising from any act, omission or state of facts that occurred or existed prior to the Closing Time, and whether
or not disclosed in any Schedule to this Agreement. The waiver of any condition based upon the accuracy of any representation and
warranty or the performance of any covenant shall not affect the right to indemnification, reimbursement or other remedy based
upon such representation, warranty or covenant.


 


	Section 7.3	Indemnification by the Purchaser



 


The Purchaser shall indemnify
and save harmless the Vendor, its Affiliates and their respective Representatives and shareholders (collectively referred to as
the “Vendor Indemnified Parties”), net of any fees, costs or expenses reasonably incurred by Vendor Indemnifying
Parties in seeking indemnification hereunder, from and against all Losses, whether or not arising due to third party claims, which
may be made or brought against any of the Vendor Indemnified Parties, or which they may suffer or incur, directly or indirectly
as a result of or in connection with or relating to:


 


		(a)	any misrepresentation or any incorrectness in or breach of any representation or warranty of the
Purchaser contained in this Agreement or in any certificate or other document furnished by or on behalf of the Purchaser pursuant
to this Agreement;



 


		(b)	any non-fulfilment or breach of any covenant or agreement on the part of the Purchaser contained
in this Agreement or in any certificate or other document furnished by or on behalf of the Purchaser pursuant to this Agreement;
and



 


		(c)	defects or deficiencies in any Product manufactured or distributed by the Business on or after
the Closing Date.



 




     


     


    

 


	Section 7.4	Claim Notice



 


If an Indemnified Party
becomes aware of any act, omission or state of facts that may give rise to Losses in respect of which a right of indemnification
is provided for under this Article 7, the Indemnified Party shall promptly give written notice thereof (a “Claim Notice”)
to the Indemnifying Party. The Claim Notice shall specify whether the potential Losses arise as a result of a claim by a Person
against the Indemnified Party (a “Third Party Claim”) or whether the potential Losses arise as a result of a
claim directly by the Indemnified Party against the Indemnifying Party (a “Direct Claim”), and shall also specify
with reasonable particularity (to the extent that the information is available):


 


		(a)	the factual basis for the Direct Claim or Third Party Claim, as the case may be; and



 


		(b)	the amount of the potential Losses arising therefrom, if known.



 


If, through the fault of the Indemnified
Party, the Indemnifying Party does not receive a Claim Notice in time effectively to contest the determination of any liability
susceptible of being contested or to assert a right to recover an amount under applicable insurance coverage, then the liability
of the Indemnifying Party to the Indemnified Party under this Article 7 shall be reduced only to the extent that Losses are actually
incurred by the Indemnifying Party resulting from the Indemnified Party’s failure to give the Claim Notice on a timely basis.
Nothing in this Section 7.4 shall be construed to affect the time within which a Claim Notice must be delivered pursuant to Section 7.5(1)
and Section 7.5(2) in order to permit recovery pursuant to Section 7.2(a) or Section 7.3(a) as the case may be.


 


	Section 7.5	Time Limits for Claim Notice for Breach of Representations
and Warranties



 


(1)          Notice
by the Purchaser. No Losses may be recovered from the Vendor pursuant to Section 7.2(a) unless (subject to the fraud
exception below) a Claim Notice is delivered by the Purchaser in accordance with the timing set out below:


 


		(a)	with respect to the representations and warranties in Section 4.1, Section 4.2, Section 4.5, Section 4.6,
and Section 4.9 (the “Vendor Fundamental Representations”) at any time within seven (7) years after Closing;



 


		(b)	with respect to the representations and warranties in Section 4.3 or Section 4.30, at any time
before the date that is ninety (90) days after the relevant Governmental Authorities are no longer entitled to assess or reassess
the Taxes in question, or Taxes arising in connection with or from the breach of such representations and warranties, having regard,
without limitation, to:



 


		(i)	any waiver given before the Closing Date in respect of such Taxes; and



 


		(ii)	any entitlement of a Governmental Authority to assess or reassess in respect of such Taxes without
limitation in the event of fraud or misrepresentation attributable to neglect, carelessness or wilful default; and



 




     


     


    

 


		(c)	with respect to all other representations and warranties, on or before the last day of the eighteenth
(18th) month following the Closing;



 


(each of (a), (b) and
(c); the “Indemnity Period”); provided, however, that in the event of fraud relating to a representation and
warranty of the Vendor in this Agreement, then notwithstanding the foregoing time limitations, the Purchaser Indemnified Parties
shall be entitled to deliver a Claim Notice at any time for purposes of such a claim. Unless (subject to the fraud exception above)
a Claim Notice has been given in accordance with the timing set out in Section 7.5(1)(a), (b) or (c), with respect to the representations
and warranties referred to in any such Section, the Vendor shall be released on the date set out in Section 7.5(1)(a), (b) or (c),
as applicable, from all obligations in respect of representations and warranties referenced in those Sections and from the obligation
to indemnify the Purchaser’s Indemnified Parties in respect thereof pursuant to Section 7.2(a).


 


(2)          Notice
by the Vendor. No Losses may be recovered from the Purchaser pursuant to Section 7.3(a) unless (subject to the fraud
exception below) a Claim Notice is delivered by the Vendor in accordance with the timing set out below:


 


		(a)	with respect to the to the representations and warranties in Section 5.1(1), (2), (3) or
(5), at any time within seven (7) years after Closing;



 


		(b)	with respect to all other representations and warranties and covenants, on or before the last day
of the eighteenth (18th) month following the Closing;



 


(each of (a) and (b);
the “Indemnity Period”); provided, however, that in the event of fraud relating to a representation and warranty
of the Purchaser in this Agreement, then notwithstanding the foregoing time limitations, the Vendor Indemnified Parties shall be
entitled to deliver a Claim Notice at any time for purposes of such a claim. Unless a Claim Notice has been given on or before
the end of the Indemnity Period with respect to each particular representation and warranty, the Purchaser shall be released at
the end of the Indemnity Period from all obligations in respect of that particular representation and warranty and from the obligation
to indemnify the Vendor’s Indemnified Parties in respect thereof pursuant to Section 7.3(a).


 


	Section 7.6	Monetary Limitations



 


(1)          Losses
from Vendor. No Losses may be recovered from the Vendor pursuant to Section 7.2 unless and until the accumulated aggregate
amount of Losses of the Purchaser’s Indemnified Parties arising pursuant to Section 7.2 exceeds $250,000, (the “Basket”),
in which event the accumulated aggregate amount of all such Losses may be recovered; provided that, in each case, the amount claimed
in respect of Losses by the Purchaser to be counted for the purpose of reaching the Basket, and only for such purpose, shall be
the net amount after excluding all costs or expenses of whatever kind, including attorneys’ fees and the cost of enforcing
any right to indemnification hereunder and the costs of pursuing any insurance providers. Such limitation shall have no application
to any claim to recover Losses based on any incorrectness in or breach of any representation or warranty of the Vendor in this
Agreement resulting from fraud by the Vendor.


 




     


     


    

 


(2)          Losses
from Purchaser. No Losses may be recovered from the Purchaser pursuant to Section 7.3 unless and until the accumulated
aggregate amount of Losses of the Vendor’s Indemnified Parties arising pursuant to Section 7.3 exceeds the Basket, in which
event the accumulated aggregate amount of all such Losses may be recovered; provided that, in each case, the amount claimed in
respect of Losses by the Vendor to be counted for the purpose of reaching the Basket, and only for such purpose, shall be the net
amount after excluding all costs or expenses of whatever kind, including attorneys’ fees and the cost of enforcing any right
to indemnification hereunder and the costs of pursuing any insurance providers. Such limitation shall have no application to any
claim to recover Losses based on any incorrectness in or breach of any representation or warranty of the Purchaser in this Agreement
resulting from fraud by the Purchaser.


 


(3)          Aggregate
Limit. The total aggregate amount of Losses that may be recovered by (a) the Purchaser’s Indemnified Parties from the
Vendor pursuant to Section 7.2 or (b) the Vendor’s Indemnified Parties from the Purchaser pursuant to Section 7.3, in each
case, shall not exceed an amount equal to 30% (thirty per cent) of the Purchase Price. Such limitation shall have no application
to any claim to recover Losses based on: (i) any incorrectness in or breach of any Vendor Fundamental Representation, in which
case the total aggregate amount of Losses that may be recovered by the Purchaser’s Indemnified Parties from the Vendor (or
the Vendor’s Indemnified Parties from the Purchaser, as the case may be) shall be the Purchase Price, or (ii) any incorrectness
in or breach of any representation or warranty of a Party in this Agreement resulting from fraud by such Party.


 


(4)          If
any Action under this Agreement is based upon a liability which is contingent or not otherwise capable of being quantified, the
relevant Party shall not be liable to pay unless and until that liability ceases to be contingent and becomes an actual liability
that is capable of being quantified.


 


(5)          The
Vendor shall not be liable for any Losses under this Agreement, to the extent that such Losses would not have arisen but for, or
have been increased or not reduced as a result of, any voluntary act, omission or transaction carried out:


 


		(a)	after Closing by the Purchasers or any of their Affiliates, where the Purchasers or any of their
Affiliates had actual knowledge or ought to reasonably have known that such act, omission or transaction would or would be likely
to give rise to or increase an Action under this Agreement; or



 


		(b)	before Closing by the Vendor or its Affiliates: (i) at the written direction or request or (ii)
with the written consent, of the Purchasers or any of their Affiliates.



 


	Section 7.7	Limitation Periods



 


The
survival period applicable to any proceeding relating to an indemnity claim hereunder shall be solely as prescribed in Section
7.5, and the Parties expressly waive the application of the Limitations Act, 2002, or any other statutory limitation
period, to this Agreement.


 




     


     


    

 


	Section 7.8	Calculation of Damages; Specific Exclusions



 


For
greater certainty, for the purpose only of calculating the amount of Losses under this Article 7, the representations and warranties
of the Parties contained in this Agreement or in any other agreement, certificate or instrument executed and delivered pursuant
to this Agreement shall be deemed to have been made without qualifications as to materiality where the words or phrases “material”,
“immaterial”, “in all material respects” or words or phrases of similar import are used, such that the
amount of Losses payable to an Indemnified Party is not subject to any deduction in respect of amounts below the level of materiality
stated in the relevant representation and warranty. 


 


EXCEPT
IN CASE OF FRAUD OR WILFUL MISCONDUCT, NEITHER PARTY WILL BE LIABLE OR OTHERWISE RESPONSIBLE TO THE OTHER PARTY OR ANY AFFILIATE
OF THE OTHER PARTY FOR ANY ECONOMIC LOSS, LOST PROFITS, COST OF PROCURING SUBSTITUTE GOODS OR SERVICES, LOST BUSINESS OR ANY INCIDENTAL,
CONSEQUENTIAL, PUNITIVE, EXEMPLARY OR OTHER SPECIAL DAMAGES SUFFERED BY THE OTHER PARTY OR ITS AFFILIATES ARISING OUT OF OR RELATED
TO THIS AGREEMENT OR THE PERFORMANCE OR BREACH HEREOF OR ANY LIABILITY RETAINED OR ASSUMED HEREUNDER FOR ALL CAUSES OF ACTION OF
ANY KIND (INCLUDING TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, INDEMNITY AND BREACH OF WARRANTY) EVEN IF SUCH PARTY HAS BEEN
ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.


 


	Section 7.9	Agency
for Non-Parties



 


Each
Party hereby accepts each indemnity in favour of each of its Indemnified Parties who are not Parties as agent and trustee of that
Indemnified Party. Each Party may enforce an indemnity in favour of any of that Party’s Indemnified Parties on behalf of
each such Indemnified Party.


 


	Section 7.10	Direct Claims



 


In
the case of a Direct Claim, the Indemnifying Party shall have 60 days from receipt of a Claim Notice in respect thereof within
which to make such investigation as the Indemnifying Party considers necessary or desirable. For the purpose of such investigation,
the Indemnified Party shall make available to the Indemnifying Party the information relied upon by the Indemnified Party to substantiate
its right to be indemnified under this Article 7, together with all such other information as the Indemnifying Party may reasonably
request. If the Parties fail to agree at or before the expiration of such 60 day period (or any mutually agreed upon extension
thereof), the Indemnified Party shall be free to pursue such remedies as may be available to it.


 




     


     


    

 


	Section 7.11	Third Party Claims



 


In
the case of a Third Party Claim, the provisions of this Section 7.11 apply.


 


		(a)	Rights of Indemnifying Party. Subject to Section 7.11(b), the Indemnifying Party shall have
the right, but not the obligation, at its expense, to assume control of the negotiation, settlement or defence of the Third Party
Claim, upon acknowledging in writing responsibility for, and agreeing to indemnify the Indemnified Party in respect of, the Third
Party Claim.



 


		(b)	Material Proceedings. The right of the Indemnifying Party to control a Third Party Claim
pursuant to this Section 7.11 shall not extend to any Third Party Claim relating to: (i) any claims asserted directly by or on
behalf of a Person that is or was a supplier or customer of the Business, (ii) any criminal or investigative proceedings in respect
of an Indemnified Party, (iii) any proceedings where preliminary or permanent injunctive relief is being sought by or against an
Indemnified Party, (iv) any claims, actions, enquiries, applications, suits, demands, arbitrations or other civil, administrative
or investigative proceedings, or other investigations or examinations by a Governmental Authority, (v) any matter that would have
a continuing material effect on the Purchaser or the Business, or (vi) any Third Party Claims where it would be inappropriate due
to actual or potential differing interests between the Indemnifying Party and an Indemnified Party (each a “Material Proceeding”);
the Indemnified Party in such case shall have the right, but not the obligation, at its expense, to assume control of the negotiation,
settlement or defence of the Material Proceeding. For the avoidance of doubt, the Indemnifying Party shall not have the right to
assume control of a Material Proceeding on an Indemnified Party’s behalf but shall be entitled to participate in the negotiation,
settlement or defence of such Material Proceeding and to retain counsel to act on its behalf, provided that the fees and disbursements
of such counsel shall be paid by the Indemnifying Party unless the Indemnified Party consents to the retention of such counsel
at its expense or unless the named parties to any action or proceeding include both the Indemnified Party and the Indemnifying
Party and a representation of both the Indemnified Party and the Indemnifying Party by the same counsel would be inappropriate
due to the actual or potential differing interests between them (such as the availability of different defences), in which case,
the fees and disbursements of such counsel shall be paid by the Indemnified Party.



 


		(c)	Respective Rights on Indemnifying Party’s Assumption of Control. If the Indemnifying
Party assumes control as contemplated in Section 7.11(a), the Indemnifying Party shall diligently proceed with the defence, compromise
or settlement of the Third Party Claim at its sole expense. The Indemnified Party shall continue to have the right to participate
in the negotiation, settlement or defence of such Third Party Claim and to retain counsel to act on its behalf, provided that the
fees and disbursements of such counsel shall be paid by the Indemnified Party unless the Indemnifying Party consents to the retention
of such counsel at its expense or unless the named parties to any action or proceeding include both the Indemnifying Party and
the Indemnified Party and a representation of both the Indemnifying Party and the Indemnified Party by the same counsel would be
inappropriate due to the actual or potential differing interests between them (such as the availability of different defences),
in which case, the fees and disbursements of such counsel shall be paid by the Indemnifying Party. The Indemnified Party shall
co-operate with the Indemnifying Party so as to permit the Indemnifying Party to conduct such negotiation, settlement and defence
and for this purpose shall preserve all relevant documents in relation to the Third Party Claim, allow the Indemnifying Party access
on reasonable notice to inspect and take copies of all such documents and require its personnel to provide such statements as the
Indemnifying Party may reasonably require and to attend and give evidence at any trial or hearing in respect of the Third Party
Claim.



 




     


     


    

 


		(d)	Lack of Reasonable Diligence. If, having elected to assume control of the negotiation, settlement
or defence of the Third Party Claim, the Indemnifying Party thereafter fails to conduct such negotiation, settlement or defence
with reasonable diligence after having received reasonable notice thereof from the Indemnified Party and an opportunity to address
any reasonable concerns raised, then the Indemnified Party shall be entitled to assume such control and the Indemnifying Party
shall be bound by the results obtained by the Indemnified Party with respect to such Third Party Claim.



 


		(e)	Necessary Payments prior to Settlement. If any Third Party Claim is of a nature such that the
Indemnified Party is required by applicable Law or any order to make a payment to any Person (a “Third Party”)
with respect to the Third Party Claim before the completion of settlement negotiations or related Actions, as the case may be,
then the Indemnified Party may make such payment and the Indemnifying Party shall promptly after demand by the Indemnified Party,
reimburse the Indemnified Party for such payment. If the amount of any Liability of the Indemnified Party under the Third Party
Claim in respect of which such a payment was made, as finally determined, is less than the amount which was paid by the Indemnifying
Party to the Indemnified Party, the Indemnified Party shall promptly pay the amount of such difference to the Indemnifying Party.



 


		(f)	Other Rights of Indemnified Party. If the Indemnifying Party fails to assume control of
the defence of any Third Party Claim after having received reasonable notice thereof from the Indemnified Party and an opportunity
to address any reasonable concerns raised, the Indemnified Party shall have the exclusive right to contest, settle or pay the amount
claimed, acting reasonably, and the Indemnifying Party shall be bound by the results obtained by the Indemnified Party with respect
to such Third Party Claim. Whether or not the Indemnifying Party assumes control of the negotiation, settlement or defence of any
Third Party Claim, the Indemnifying Party shall not settle any Third Party Claim without the written consent of the Indemnified
Party, which consent shall not be unreasonably withheld or delayed.



 




     


     


    

 


	Section 7.12	Exclusive Remedy



 


The rights of indemnity
set forth in this Article 7 are the sole and exclusive remedy of each Party in respect of any misrepresentation, incorrectness
in or breach of any representation or warranty, or breach of covenant, by the other Party under this Agreement but are not, for
clarity, the sole and exclusive remedy under any instruments or documents delivered pursuant to this Agreement. Accordingly, the
Parties waive, from and after the Closing, any and all rights, remedies and claims that the Purchaser may have against a Vendor
or a Vendor may have against the Purchaser, whether at Law or in equity (including but not limited to claims for contribution or
other rights of recovery arising under any Environmental Laws, claims for breach of contract, breach of representation and warranty,
negligent misrepresentation and all claims for breach of duty), or otherwise, directly or indirectly, relating to the provisions
of this Agreement or the transactions contemplated by this Agreement other than as expressly provided for in this Article 7, other
than those arising with respect to any fraud or wilful misconduct and other than those provided for in other documents or instruments
delivered pursuant to this Agreement. The Parties agree that if an Action for indemnification is made by one Party in accordance
with this Article 7 as the case may be, and there has been a refusal by another Party to make payment or otherwise provide satisfaction
in respect of such Action, then a legal proceeding is the appropriate means to seek a remedy for such refusal. This Article 7 shall
remain in full force and effect in all circumstances and shall not be terminated by any breach (fundamental, negligent or otherwise)
by any Party of its representations, warranties or covenants under this Agreement or under any Closing document or by any termination
or rescission of this Agreement by any Party.


 


	Section 7.13	No Double Counting



 


Notwithstanding
any other provision of this Agreement, the Purchaser Indemnified Parties shall not be entitled to recover from the Vendor under
this Agreement (or any other agreement to which the Vendor is a party with the Purchaser or its Affiliates) more than once in respect
of the same damage suffered and the limitations on liability shall be construed accordingly. 


 


Article
8 – Post-Closing covenants


 


	Section 8.1	General



 


In the event that at any time after the
Closing Date any further action is reasonably necessary to carry out the purposes of this Agreement, each Party will take such
further action (including the execution and delivery of such further instruments and documents) as the other Party reasonably may
request, at the sole cost and expense of the requesting Party (unless otherwise specified herein).


 


	Section 8.2	Delayed Transfer Assets and Obligations



 


(1)          Delayed
Transfer Assets. To the extent that any Purchased Asset or any claim, right or benefit arising under or resulting from such
Purchased Asset is not capable of being transferred without the approval, consent or waiver of any Third Party which has not yet
been obtained, or if the transfer of any Purchased Asset would constitute a breach of any obligation under, or a violation of,
any applicable Law, in each case unless the approval, consent or waiver of such Third Party is obtained (all such Purchased Assets
being collectively referred to in this Agreement as “Delayed Transfer Assets”), except as otherwise expressly
provided in this Agreement, this Agreement shall not constitute an agreement to transfer any Delayed Transfer Asset unless and
until such approval, consent or waiver has been obtained. After the Closing and until all such Delayed Transfer Assets are transferred
to the Purchaser, the Vendor shall:  


 




     


     


    

 


		(a)	hold the Delayed Transfer Assets in trust for the Purchaser;



 


		(b)	comply with the terms and provisions of or relating to the Delayed Transfer Assets as agent for
the Purchaser, provided the Purchaser attends to all payments and costs required to be made in respect of such Delayed Transfer
Assets;



 


		(c)	co-operate with the Purchaser at the Purchaser’s expense in any reasonable and lawful arrangements
designed to provide the benefits of the Delayed Transfer Assets to the Purchaser; and



 


		(d)	enforce, at the request of the Purchaser and at the expense and for the account of the Purchaser,
any rights of the Vendor under or arising from the Delayed Transfer Assets against any Third Party, including the right to elect
to terminate any such rights in accordance with the terms of such rights upon the written direction of the Purchaser.



 


In order that the full value of the Delayed
Transfer Assets may be realized for the benefit of the Purchaser, the Vendor shall, at the request and expense and under the direction
of the Purchaser, in the name of the Vendor or otherwise as the Purchaser may specify, take all such action and do or cause to
be done all such things as are, in the opinion of the Purchaser, necessary or proper in order that the obligations of the Vendor
under such Delayed Transfer Assets may be performed in such manner that the value of such Delayed Transfer Assets is preserved
and enures to the benefit of the Purchaser, and that any moneys due and payable and to become due and payable to the Purchaser
in and under such Delayed Transfer Assets are received by the Purchaser. The Vendor shall, subject as hereinafter set forth, pay
to the Purchaser all moneys collected by or paid to the Vendor in respect of every such Delayed Transfer Asset. In the event that
the Vendor is entitled to be paid for any expense or cost incurred or to be incurred in respect of any Delayed Transfer Asset as
contemplated in this Section 8.2(1) which has not been paid to and received by the Vendor, the Vendor shall be entitled to
set off and deduct from any payment to be made to the Purchaser as contemplated in the immediately preceding sentence of this Section 8.2(1)
all such amounts in satisfaction of such obligation of the Purchaser.


 


	Section 8.3	Wrong Pockets Covenant



 


Without
prejudice to any other rights or remedies of the Purchaser under this Agreement, if any Party becomes aware that any Purchased
Asset has not vested in the Purchaser by virtue of the transactions carried out under this Agreement, the Party becoming aware
of such matter shall, in relation to such Purchased Asset, immediately give written notice of this to the other Party. If such
notice is given:


 


		(a)	the Vendor and its Affiliates shall, as soon as practicable at their own cost, transfer or procure
the transfer of such Purchased Asset or other asset to the Purchaser for no additional consideration; and



 




     


     


    

 


		(b)	each Party shall provide such assistance to the other Parties as it reasonably requires for the
purposes of this Section 8.3.



 


	Section 8.4	Vendor’s Corporate Name



 


Promptly
following the Closing, and in any event no later than 30 days following the Closing, the Vendor shall provide evidence to the Purchaser
that the Vendor has changed its name from “Alveda Pharmaceuticals Inc.” to such other name that does not incorporate
any of the Vendor’s Intellectual Property at the time of the Closing. In the event the Purchaser does not use the name “Alveda
Pharmaceuticals Inc.” for a period of 12 consecutive months at any time following the Closing Date; and, in any event, on
the third (3rd) anniversary of the Closing Date; the Purchaser agrees that the Vendor shall have the option to reacquire
all rights, title and interest in the name “Alveda Pharmaceuticals Inc.” for consideration of $1.00. Upon the exercise
of the said option by the Vendor (which may be exercised by way of simple notice to the Purchaser), the name shall be transferred
back to the Vendor as soon as practicable, and the Purchaser shall do all such things as may be necessary to effect the said transfer
without delay.


 


Article
9 — MISCELLANEOUS


 


	Section 9.1	Tax Returns



 


Each of the Vendor
and the Purchaser shall file their Tax Returns in respect of the period including the Closing Date in a manner consistent with
the provisions hereof, and shall coordinate the filing of any elections, including matters relating to the allocation of the Purchase
Price, as contemplated herein.


 


	Section 9.2	Public Notice



 


Parties shall jointly
plan and co-ordinate any public notices, press releases, and any other publicity concerning the transactions contemplated by this
Agreement and no Party shall act in this regard without the prior approval of the other, such approval not to be unreasonably withheld,
except where such disclosure is required to meet disclosure obligations of any Party under Laws or stock exchange rules and a copy
of such disclosure is provided to the other Party.


 


	Section 9.3	Expenses



 


Except
as otherwise provided in this Agreement, each of the Purchaser and the Vendor shall pay all costs and expenses (including the fees
and disbursements of legal counsel and other advisers) it incurs in connection with the negotiation, preparation and execution
of this Agreement and the transactions contemplated by this Agreement.


 


	Section 9.4	Notices



 


Any notice, consent
or approval required or permitted to be given in connection with this Agreement (in this Article referred to as a “Notice”)
shall be in writing and shall be sufficiently given if delivered (whether in person, by courier service or other personal method
of delivery), or if transmitted by facsimile or e-mail:


 




     


     


    

 


In the case of Purchaser:


 


IGI Laboratories,
Inc.


105 Lincoln Avenue


Buena, New Jersey
08310


Attention to:
Jenniffer Collins

Email: jenniffercollins@igilabs.com


 


With a copy (which
will not constitute notice) to:


 


Blake, Cassels
& Graydon LLP

Attention to: Christopher Jones


199 Bay Street,
Suite 4000


Commerce Court
West


Toronto, ON


M5L 1A9


Fax: 416.863.2653

Email: christopher.jones@blakes.com


 


In the case of the Vendor:


 


Alveda Pharmaceuticals
Inc.


21 St. Clair
Avenue East, Suite 1100


Toronto, ON


M4T 1L9


Attention to:
Albert Beraldo


Fax: 1-416-485-8352

Email: albert.beraldo@alvedapharma.com


 


With a copy
(which will not constitute notice) to:


 


CMS Cameron McKenna


14 Tsar Osvoboditel
Blvd., Fl. 1


Sofia 1000,
Bulgaria


Attention to:
David Butts


Fax: 011 3952
921 9948

Email: david.butts@cms-cmck.com


 


And with a copy
(which will not constitute notice) to:


 


Greenspoon Bellemare
LLP


1002 Sherbrooke
Street West, Suite 1900


Montreal, QC


H3A 3A2


Attention to:
Lyanne Winikoff


Fax: 1-514-499-9829


Email: lwinikoff@gplegal.com


 




     


     


    

 


Any Notice delivered or transmitted to
a Party as provided above shall be deemed to have been given and received on the day it is delivered or transmitted, provided that
it is delivered or transmitted on a Business Day prior to 5:00 p.m. local time in the place of delivery or receipt. However, if
the Notice is delivered or transmitted after 5:00 p.m. local time or if such day is not a Business Day then the Notice shall be
deemed to have been given and received on the next Business Day.


 


Any Party may, from time to time, change
its address by giving Notice to the other Parties in accordance with the provisions of this Article.


 


	Section 9.5	Assignment



 


No
Party to this Agreement may assign any of its rights or obligations under this Agreement including by sale of stock or, except
as set forth in item (ii) below, by operation of Law, without the prior written consent of the other Party hereto; provided, however,
that nothing in the foregoing shall prohibit the Purchaser or the Vendor from making any assignment (i) to any of its Affiliates
so long as such Affiliate agrees in writing to be bound by all of the terms, conditions and provisions contained in this Agreement;
provided, further, that no such assignment shall release the Purchaser or the Vendor, as the case may be, from its obligations
under this Agreement; and (ii) to any successors to all or substantially all of the business and assets of the Purchaser or the
Seller, whether in a merger, consolidation, sale of substantially all assets or other similar transaction. Any purported assignment,
hypothecation or transfer in breach of this Section 9.5 shall be null and void. The Purchaser shall be entitled, upon giving notice
to the Vendor at any time not less than 2 days prior to the Closing Date, to assign all of its rights and obligations under this
Agreement to any Affiliate of such Purchaser.


 


	Section 9.6	Enurement



 


This Agreement enures
to the benefit of and is binding upon the Parties and their respective heirs, attorneys, guardians, estate trustees, executors,
trustees and permitted assigns.


 


	Section 9.7	Amendment



 


No amendment, supplement,
modification or waiver or termination of this Agreement and, unless otherwise specified, no consent or approval by any Party, is
binding unless executed in writing by the Party to be bound thereby.


 


	Section 9.8	Further Assurances



 


The Parties shall,
with reasonable diligence, do all such things and provide all such reasonable assurances as may be required to consummate the transactions
contemplated by this Agreement, and each Party shall provide such further documents or instruments required by any other Party
as may be reasonably necessary or desirable to effect the purpose of this Agreement and carry out its provisions, whether before
or after the Closing.


 




     


     


    

 


	Section 9.9	Independent Legal Advice



 


The Vendor acknowledges
that it has been advised to seek independent legal counsel in respect of this Agreement and the matters contemplated herein. To
the extent that the Vendor decline to receive independent legal advice in respect of this Agreement, the Vendor hereby waives the
right, should a dispute later develop, to rely on the lack of independent legal counsel to avoid the obligations of the Vendor
herein, to seek indulgences from the Purchaser, or to otherwise attack the integrity of this Agreement and the provisions hereof,
in whole or in part.


 


	Section 9.10	Execution and Delivery



 


This Agreement may
be executed by the Parties in counterparts and may be executed and delivered by facsimile and all such counterparts and facsimiles
together constitute one and the same agreement.


 


[Signature Page Follows]


 




     


     


    

 


IN WITNESS WHEREOF
the Parties have executed this Agreement on the date first above written.


 


 


	 	IGI LABORATORIES, INC.
	 	 
	 	Per:	/s/ Jason Grenfell-Gardner
	 	 	Name: Jason Grenfell-Gardner
	 	 	Title:   President and CEO


 


	 	ALVEDA PHARMACEUTICALS INC.
	 	 
	 	Per:	/s/ Albert Beraldo
	 	 	Name: Albert Beraldo
	 	 	Title:   President